WO2021132468A1 - 甘味の増大した経口組成物 - Google Patents
甘味の増大した経口組成物 Download PDFInfo
- Publication number
- WO2021132468A1 WO2021132468A1 PCT/JP2020/048464 JP2020048464W WO2021132468A1 WO 2021132468 A1 WO2021132468 A1 WO 2021132468A1 JP 2020048464 W JP2020048464 W JP 2020048464W WO 2021132468 A1 WO2021132468 A1 WO 2021132468A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sweetness
- less
- oral composition
- amino acid
- sweetener
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 166
- 230000001965 increasing effect Effects 0.000 title abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 25
- 238000004519 manufacturing process Methods 0.000 claims abstract description 13
- 230000002708 enhancing effect Effects 0.000 claims abstract description 11
- 235000003599 food sweetener Nutrition 0.000 claims description 149
- 239000003765 sweetening agent Substances 0.000 claims description 149
- 235000001014 amino acid Nutrition 0.000 claims description 141
- 150000001413 amino acids Chemical class 0.000 claims description 136
- 235000019640 taste Nutrition 0.000 claims description 84
- 150000003839 salts Chemical class 0.000 claims description 47
- 235000013361 beverage Nutrition 0.000 claims description 46
- 229930006000 Sucrose Natural products 0.000 claims description 35
- 239000005720 sucrose Substances 0.000 claims description 35
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 34
- 239000000284 extract Substances 0.000 claims description 34
- 235000000346 sugar Nutrition 0.000 claims description 33
- 235000013305 food Nutrition 0.000 claims description 29
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8s,9r,10r,11r,13r,14s,17r)-17-[(2r,5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims description 26
- TVJXHJAWHUMLLG-UHFFFAOYSA-N mogroside V Natural products CC(CCC(OC1OC(COC2OC(CO)C(O)C(O)C2OC3OC(CO)C(O)C(O)C3O)C(O)C(O)C1O)C(C)(C)O)C4CCC5(C)C6CC=C7C(CCC(OC8OC(COC9OC(CO)C(O)C(O)C9O)C(O)C(O)C8O)C7(C)C)C6(C)C(O)CC45C TVJXHJAWHUMLLG-UHFFFAOYSA-N 0.000 claims description 26
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 22
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 21
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 21
- 239000008103 glucose Substances 0.000 claims description 21
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 18
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 15
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 14
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 13
- 229930091371 Fructose Natural products 0.000 claims description 12
- 239000005715 Fructose Substances 0.000 claims description 12
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 12
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 11
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 11
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 11
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 11
- 239000008101 lactose Substances 0.000 claims description 11
- 239000004475 Arginine Substances 0.000 claims description 10
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 claims description 10
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 10
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 10
- 235000004279 alanine Nutrition 0.000 claims description 10
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 10
- 229920001542 oligosaccharide Polymers 0.000 claims description 10
- 150000005846 sugar alcohols Chemical class 0.000 claims description 10
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 claims description 9
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 8
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 8
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 8
- 150000002482 oligosaccharides Chemical class 0.000 claims description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 7
- 229930182817 methionine Natural products 0.000 claims description 7
- 230000007935 neutral effect Effects 0.000 claims description 7
- 208000007976 Ketosis Diseases 0.000 claims description 6
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 6
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 claims description 6
- 150000002584 ketoses Chemical class 0.000 claims description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 150000002402 hexoses Chemical class 0.000 claims description 5
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 5
- 150000002972 pentoses Chemical class 0.000 claims description 5
- 150000003538 tetroses Chemical class 0.000 claims description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 239000011593 sulfur Substances 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 claims description 3
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims 1
- 239000012141 concentrate Substances 0.000 abstract description 17
- 229940024606 amino acid Drugs 0.000 description 130
- 235000009508 confectionery Nutrition 0.000 description 49
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 40
- 239000000126 substance Substances 0.000 description 37
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 31
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 28
- 239000004615 ingredient Substances 0.000 description 24
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 23
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 22
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 20
- -1 chewables Substances 0.000 description 20
- 229960002429 proline Drugs 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 18
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 18
- 239000004473 Threonine Substances 0.000 description 17
- 229960003136 leucine Drugs 0.000 description 17
- 229960002898 threonine Drugs 0.000 description 17
- 235000008504 concentrate Nutrition 0.000 description 16
- 239000004471 Glycine Substances 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 14
- 229960001153 serine Drugs 0.000 description 14
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 13
- 229960003767 alanine Drugs 0.000 description 13
- 239000002994 raw material Substances 0.000 description 13
- 229960004295 valine Drugs 0.000 description 13
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 12
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 12
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 12
- 229960001230 asparagine Drugs 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 235000005772 leucine Nutrition 0.000 description 12
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 11
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 11
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 11
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 11
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 11
- 235000013399 edible fruits Nutrition 0.000 description 11
- 229960002989 glutamic acid Drugs 0.000 description 11
- 229930182821 L-proline Natural products 0.000 description 10
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 10
- 229960005261 aspartic acid Drugs 0.000 description 10
- 229960000310 isoleucine Drugs 0.000 description 10
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 10
- 235000013930 proline Nutrition 0.000 description 10
- 235000010436 thaumatin Nutrition 0.000 description 10
- 239000000892 thaumatin Substances 0.000 description 10
- 235000008521 threonine Nutrition 0.000 description 10
- 229960004799 tryptophan Drugs 0.000 description 10
- 239000001329 FEMA 3811 Substances 0.000 description 9
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 9
- 239000004472 Lysine Substances 0.000 description 9
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 9
- 235000009697 arginine Nutrition 0.000 description 9
- 229960003121 arginine Drugs 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 229950010030 dl-alanine Drugs 0.000 description 9
- 229960002885 histidine Drugs 0.000 description 9
- 229960003646 lysine Drugs 0.000 description 9
- 229960004452 methionine Drugs 0.000 description 9
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 9
- 235000010434 neohesperidine DC Nutrition 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 230000001953 sensory effect Effects 0.000 description 9
- 150000008163 sugars Chemical group 0.000 description 9
- 230000001149 cognitive effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 8
- 235000004554 glutamine Nutrition 0.000 description 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 8
- 235000018977 lysine Nutrition 0.000 description 8
- 229960005190 phenylalanine Drugs 0.000 description 8
- 235000004400 serine Nutrition 0.000 description 8
- 239000004474 valine Substances 0.000 description 8
- 235000014393 valine Nutrition 0.000 description 8
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 7
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 7
- 235000009582 asparagine Nutrition 0.000 description 7
- 235000003704 aspartic acid Nutrition 0.000 description 7
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 7
- 235000014171 carbonated beverage Nutrition 0.000 description 7
- 229960002449 glycine Drugs 0.000 description 7
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 7
- 235000014304 histidine Nutrition 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- SRBFZHDQGSBBOR-SOOFDHNKSA-N D-ribopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@@H]1O SRBFZHDQGSBBOR-SOOFDHNKSA-N 0.000 description 6
- 239000004386 Erythritol Substances 0.000 description 6
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 6
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- 229930064664 L-arginine Natural products 0.000 description 6
- 235000014852 L-arginine Nutrition 0.000 description 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 244000228451 Stevia rebaudiana Species 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000019414 erythritol Nutrition 0.000 description 6
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 6
- 229940009714 erythritol Drugs 0.000 description 6
- 235000013350 formula milk Nutrition 0.000 description 6
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 6
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 6
- 229960004949 glycyrrhizic acid Drugs 0.000 description 6
- 235000019410 glycyrrhizin Nutrition 0.000 description 6
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 235000006109 methionine Nutrition 0.000 description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 6
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 5
- 239000004378 Glycyrrhizin Substances 0.000 description 5
- 229930182816 L-glutamine Natural products 0.000 description 5
- 239000004395 L-leucine Substances 0.000 description 5
- 235000019454 L-leucine Nutrition 0.000 description 5
- 244000269722 Thea sinensis Species 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 235000013922 glutamic acid Nutrition 0.000 description 5
- 239000004220 glutamic acid Substances 0.000 description 5
- 229960002743 glutamine Drugs 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 235000019533 nutritive sweetener Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229960002920 sorbitol Drugs 0.000 description 5
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 4
- 244000179853 Sideroxylon dulcificum Species 0.000 description 4
- 235000011341 Sideroxylon dulcificum Nutrition 0.000 description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 4
- 235000013405 beer Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000013353 coffee beverage Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000015203 fruit juice Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940069445 licorice extract Drugs 0.000 description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 4
- 229930189775 mogroside Natural products 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 235000010356 sorbitol Nutrition 0.000 description 4
- 235000019202 steviosides Nutrition 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229960004441 tyrosine Drugs 0.000 description 4
- 239000000811 xylitol Substances 0.000 description 4
- 235000010447 xylitol Nutrition 0.000 description 4
- 229960002675 xylitol Drugs 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- 241000722718 Capparis masaikai Species 0.000 description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 3
- 241000218165 Dioscoreophyllum Species 0.000 description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 description 3
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 3
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 3
- 229930195722 L-methionine Natural products 0.000 description 3
- 240000006284 Molineria latifolia Species 0.000 description 3
- 241001092459 Rubus Species 0.000 description 3
- YWPVROCHNBYFTP-UHFFFAOYSA-N Rubusoside Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC1OC(CO)C(O)C(O)C1O YWPVROCHNBYFTP-UHFFFAOYSA-N 0.000 description 3
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- 244000185386 Thladiantha grosvenorii Species 0.000 description 3
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 235000013334 alcoholic beverage Nutrition 0.000 description 3
- 150000001323 aldoses Chemical class 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 108010010165 curculin Proteins 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229940049906 glutamate Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229960002591 hydroxyproline Drugs 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229960005337 lysine hydrochloride Drugs 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- YWPVROCHNBYFTP-OSHKXICASA-N rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000014214 soft drink Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000013322 soy milk Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 210000001779 taste bud Anatomy 0.000 description 3
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- HOMROMWVNDUGRI-RVZXSAGBSA-N (2s)-2-aminopentanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O HOMROMWVNDUGRI-RVZXSAGBSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 2
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 2
- LKDRXBCSQODPBY-OEXCPVAWSA-N D-tagatose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@@H]1O LKDRXBCSQODPBY-OEXCPVAWSA-N 0.000 description 2
- 206010056474 Erythrosis Diseases 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 101000659765 Homo sapiens Taste receptor type 1 member 2 Proteins 0.000 description 2
- 101000659774 Homo sapiens Taste receptor type 1 member 3 Proteins 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 244000267823 Hydrangea macrophylla Species 0.000 description 2
- 235000014486 Hydrangea macrophylla Nutrition 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- 229930182844 L-isoleucine Natural products 0.000 description 2
- BJHIKXHVCXFQLS-ZXEDONINSA-N L-psicose Chemical compound OC[C@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-ZXEDONINSA-N 0.000 description 2
- 244000292467 Lippia dulcis Species 0.000 description 2
- 235000000144 Lippia dulcis Nutrition 0.000 description 2
- 101710084933 Miraculin Proteins 0.000 description 2
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 2
- 241000157406 Pentadiplandra brazzeana Species 0.000 description 2
- 241001522306 Serinus serinus Species 0.000 description 2
- 239000004383 Steviol glycoside Substances 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 102100035948 Taste receptor type 1 member 2 Human genes 0.000 description 2
- 102100035942 Taste receptor type 1 member 3 Human genes 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- PHKGGXPMPXXISP-DFWYDOINSA-N azanium;(4s)-4-amino-5-hydroxy-5-oxopentanoate Chemical compound [NH4+].[O-]C(=O)[C@@H]([NH3+])CCC([O-])=O PHKGGXPMPXXISP-DFWYDOINSA-N 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020510 functional beverage Nutrition 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 108091005708 gustatory receptors Proteins 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000020888 liquid diet Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 2
- 239000013588 oral product Substances 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- 235000019600 saltiness Nutrition 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 235000011496 sports drink Nutrition 0.000 description 2
- 235000019411 steviol glycoside Nutrition 0.000 description 2
- 229930182488 steviol glycoside Natural products 0.000 description 2
- 150000008144 steviol glycosides Chemical class 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 150000003445 sucroses Chemical class 0.000 description 2
- 235000021091 sugar-based sweeteners Nutrition 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000015041 whisky Nutrition 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- RMLYXMMBIZLGAQ-UHFFFAOYSA-N (-)-monatin Natural products C1=CC=C2C(CC(O)(CC(N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-UHFFFAOYSA-N 0.000 description 1
- IFQSXNOEEPCSLW-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride Chemical compound Cl.SCC(N)C(O)=O IFQSXNOEEPCSLW-UHFFFAOYSA-N 0.000 description 1
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2r,3r,4s,5s,6r)-2-[[(2r,3s,4s,5r,6r)-6-[[(3s,8r,9r,10s,11r,13r,14s,17r)-17-[(5r)-5-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 description 1
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
- CPYVQXAASIFAMD-KNIFDHDWSA-N (2s)-2-aminobutanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.NCCCC[C@H](N)C(O)=O CPYVQXAASIFAMD-KNIFDHDWSA-N 0.000 description 1
- JFOWDKWFHZIMTR-RUCXOUQFSA-N (2s)-2-aminopentanedioic acid;(2s)-2,5-diamino-5-oxopentanoic acid Chemical compound OC(=O)[C@@H](N)CCC(N)=O.OC(=O)[C@@H](N)CCC(O)=O JFOWDKWFHZIMTR-RUCXOUQFSA-N 0.000 description 1
- AXSWUQQYLYWEMJ-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;calcium Chemical compound [Ca].OC(=O)[C@@H](N)CCC(O)=O AXSWUQQYLYWEMJ-DFWYDOINSA-N 0.000 description 1
- VCXSLYSWQMBISB-DFWYDOINSA-N (2s)-2-aminopentanedioic acid;potassium Chemical compound [K].OC(=O)[C@@H](N)CCC(O)=O VCXSLYSWQMBISB-DFWYDOINSA-N 0.000 description 1
- OOGFPFWTORZYAN-AQHGXSAQSA-N (2s,4r)-4-oxidanylpyrrolidine-2-carboxylic acid Chemical compound O[C@H]1CN[C@H](C(O)=O)C1.O[C@H]1CN[C@H](C(O)=O)C1 OOGFPFWTORZYAN-AQHGXSAQSA-N 0.000 description 1
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2s,4s)-4-amino-2-hydroxy-2-(1h-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- SRVDSBJOEBIJQT-UHFFFAOYSA-N 2-azanyl-4-methylsulfanyl-butanoic acid Chemical compound CSCCC(N)C(O)=O.CSCCC(N)C(O)=O SRVDSBJOEBIJQT-UHFFFAOYSA-N 0.000 description 1
- XVTAQSGZOGYIEY-UHFFFAOYSA-N 3,4-dihydroisocoumarin Chemical compound C1=CC=C2C(=O)OCCC2=C1 XVTAQSGZOGYIEY-UHFFFAOYSA-N 0.000 description 1
- QAWLKTDBUQOFEF-UHFFFAOYSA-N 3-(4-bromophenyl)propanenitrile Chemical compound BrC1=CC=C(CCC#N)C=C1 QAWLKTDBUQOFEF-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- RVEWUBJVAHOGKA-WOYAITHZSA-N Arginine glutamate Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RVEWUBJVAHOGKA-WOYAITHZSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-altritol Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PUFIMZNGSA-N D-psicose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-PUFIMZNGSA-N 0.000 description 1
- LKDRXBCSQODPBY-IANNHFEVSA-N D-sorbose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-IANNHFEVSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- DATAGRPVKZEWHA-UHFFFAOYSA-N L-gamma-glutamyl-n-ethylamine Natural products CCNC(=O)CCC(N)C(O)=O DATAGRPVKZEWHA-UHFFFAOYSA-N 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108050004114 Monellin Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- 241000157404 Pentadiplandra Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- 241000034699 Sclerochiton Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 description 1
- 208000025371 Taste disease Diseases 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000013532 brandy Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- UMVAYAXXQSFULN-QHTZZOMLSA-L calcium;(2s)-2-aminopentanedioate;hydron Chemical compound [Ca+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O UMVAYAXXQSFULN-QHTZZOMLSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000014080 ginger ale Nutrition 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940072008 glycyrrhiza glabra extract Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- BJHIKXHVCXFQLS-LFRDXLMFSA-N keto-L-tagatose Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)C(=O)CO BJHIKXHVCXFQLS-LFRDXLMFSA-N 0.000 description 1
- BRHPBVXVOVMTIQ-ZLELNMGESA-N l-leucine l-leucine Chemical compound CC(C)C[C@H](N)C(O)=O.CC(C)C[C@H](N)C(O)=O BRHPBVXVOVMTIQ-ZLELNMGESA-N 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- MYUGVHJLXONYNC-QHTZZOMLSA-L magnesium;(2s)-2-amino-5-hydroxy-5-oxopentanoate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CCC(O)=O.[O-]C(=O)[C@@H](N)CCC(O)=O MYUGVHJLXONYNC-QHTZZOMLSA-L 0.000 description 1
- MYUGVHJLXONYNC-QHTZZOMLSA-J magnesium;(2s)-2-aminopentanedioate Chemical compound [Mg+2].[O-]C(=O)[C@@H](N)CCC([O-])=O.[O-]C(=O)[C@@H](N)CCC([O-])=O MYUGVHJLXONYNC-QHTZZOMLSA-J 0.000 description 1
- 235000021577 malt beverage Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000019656 metallic taste Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229930191869 mogroside IV Natural products 0.000 description 1
- OKGRRPCHOJYNKX-UHFFFAOYSA-N mogroside IV A Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O OKGRRPCHOJYNKX-UHFFFAOYSA-N 0.000 description 1
- WRPAFPPCKSYACJ-UHFFFAOYSA-N mogroside IV E Natural products C1CC2(C)C3CC=C(C(C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)C(CO)O5)O)O4)O)CC4)(C)C)C4C3(C)C(O)CC2(C)C1C(C)CCC(C(C)(C)O)OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O WRPAFPPCKSYACJ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000000879 neohesperidine DC Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical group 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical compound C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- HQEROMHPIOLGCB-DFWYDOINSA-M potassium;(2s)-2-aminopentanedioate;hydron Chemical compound [K+].[O-]C(=O)[C@@H](N)CCC(O)=O HQEROMHPIOLGCB-DFWYDOINSA-M 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 229930188195 rebaudioside Natural products 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 235000020083 shōchū Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 description 1
- 229940032084 steviol Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 210000000225 synapse Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000013529 tequila Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 235000012184 tortilla Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/31—Artificial sweetening agents containing amino acids, nucleotides, peptides or derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/36—Terpene glycosides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to an oral composition having an increased sweetness and a method for producing the oral composition.
- the present invention also relates to a method for enhancing the sweetness of an oral composition and a concentrate for providing the oral composition.
- Taste receptors called taste buds are present in the mushroom-shaped papillae that exist in a wide range around the tip of the tongue, and the circumvallate papillae and foliate papillae that exist in a limited area in the back of the tongue. There is.
- Taste buds are cell aggregates composed of elongated taste cells and basal cells. Taste cells produce fine line hairs toward the tongue, and at the bottom of the cells, they make synapses with taste nerve fibers that invade the taste buds, and the taste that we usually feel is sent to the brain via the taste nerve as taste information and recognized.
- T1R2 and T1R3 are known as sweet taste receptors. It has been reported that T1R2 and T1R3 form heterodimers (Non-Patent Documents 1 to 3).
- Non-Patent Document 4 As an example of the contrast effect, which is one of the taste interactions, it has long been known that the sweetness increases when salt is added to soup powder. There are examples of reports on the interaction between saltiness and sweetness focusing on this phenomenon, but the interaction between sweetness and saltiness has a somewhat strong sweetness (15% solution) and a somewhat strong salt concentration (0.1 to 0.2%). It has been concluded that this is required (Non-Patent Document 4).
- Patent Document 1 It is also being studied to increase the sweetness by adding a low concentration of sodium to natural sugar and a specific high-sweetness sweetener.
- the present inventors have succeeded for the first time in increasing the sweetness of a high-sweetness sweetener by blending a specific high-sweetness sweetener with a low-concentration amino acid or a derivative thereof or a salt thereof that cannot be perceived by humans. did.
- the present invention includes the following aspects of the invention.
- It contains (a) a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, and (b) an amino acid below the taste recognition threshold or a derivative thereof or a salt thereof.
- An oral composition having a sweetness intensity of Xb due to the components (a) and (b), and 0.1 ⁇ Xa ⁇ Xb.
- the amino acid comprises a basic amino acid, a neutral amino acid having an alkyl group, an OH group, a sulfur-containing group or an imino group in the side chain, and an amino acid selected from a combination thereof.
- the amino acid comprises an amino acid selected from alanine, serine, proline, methionine and arginine and combinations thereof.
- the good-tasting, high-sweetness sweetener comprises rebaugioside D, rebaugioside M, mogroside V, Luo Han Guo extract and a combination thereof.
- Oral composition [7] The oral composition according to [5] or [6], wherein the low-sweetness sweetener comprises a sweetener selected from hexose, pentose, tetrose, a polysaccharide having an aldose or ketose terminal sugar, a sugar alcohol, and a combination thereof. Stuff.
- the low sweetness sweetener comprises a sweetener selected from hexoses, pentoses, tetrose, polysaccharides having aldose or ketose terminal sugars, sugar alcohols and combinations thereof, [5], [6] or [6-1].
- the oral composition according to. [8] The low sweetness sweetener comprises a sweetener selected from glucose, sucrose, fructose, maltose, oligosaccharides, high fructose corn syrup, lactose, psicose, allose, tagatose, xylose, ribose and combinations thereof, [5] or The oral composition according to [6].
- the low-sweetness sweetener comprises a sweetener selected from glucose, sucrose, fructose, maltose, oligosaccharides, high fructose corn syrup, lactose, psicose, allose, tagatose, xylose, ribose and combinations thereof, [5].
- the oral composition according to any one of [1] to [8-1] which is a food product.
- the oral composition according to [9] wherein the food is a beverage.
- the method for producing an oral composition according to any one of. [12] A method for enhancing the sweetness of the oral composition, which comprises adding an amino acid below the taste recognition threshold to the oral composition containing a good-quality, high-sweetness sweetener.
- the present invention provides an oral composition having an enhanced sweetness rather than a simple sweetness obtained by increasing the amount of a good-tasting, high-sweetness sweetener used.
- oral composition of the present invention provides, as a first aspect, the following oral composition (hereinafter, referred to as “oral composition of the present invention”).
- A Good-quality, high-sweetness sweetener in an amount equivalent to sweetness intensity Xa
- b Contains amino acids below the taste recognition threshold or derivatives thereof or salts thereof.
- the component exhibiting sweetness is (a) a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, and the sweetness exhibited by the oral composition of the present invention is calculated. It should have a sweetness intensity of Xa. However, since (b) amino acids or derivatives thereof or salts thereof, which are low in concentration but below the taste recognition threshold, are present in the oral composition, (a) sweetness intensity Xa equivalent amount of good quality, high sweetness, and sweetness The sweetness of the agent is increased to the sweetness intensity Xb (where 0.1 ⁇ Xa ⁇ Xb).
- the present invention means that in addition to these components (a) and (b), additional components such as acidulants, flavors and extracts may be included.
- the oral composition according to one aspect of the present invention does not contain any sweetening component other than (a) a good taste, high sweetness, and sweetening agent in an amount equivalent to the sweetness intensity Xa.
- oral composition is a general term for solids, fluids, and liquids, and mixtures thereof, which are orally edible.
- the oral composition of the present invention includes foods, and foods include beverages.
- Examples of the oral composition of the present invention include dietary supplements, health foods, functional foods, infant foods, infant formulas, premature infant formulas, geriatric foods and the like.
- Dietary supplements are foods that are fortified with specific nutritional components.
- Health foods are foods that are healthy or good for health, and include dietary supplements, natural foods, diet foods, and the like.
- Functional foods are foods for supplementing nutritional components that fulfill the body's regulatory function, and are synonymous with foods for specified health uses.
- Infant food is food for children up to about 6 years old.
- Geriatric foods are foods that have been processed to be easier to digest and absorb than untreated foods.
- Infant formula refers to formula for feeding to children up to about 1 year old.
- Premature infant formula refers to formula for premature infants to be fed until about 6 months of age.
- the form of the oral composition is not particularly limited, and various forms can be used. Examples of such forms include beverages, confectioneries, supplements and the like.
- the beverage may be either an alcoholic beverage or a non-alcoholic beverage.
- Non-alcoholic beverages include, for example, non-alcoholic beer, malt beverage, lactic acid bacterium beverage, cocoa, sports drink, nutritional drink, tea-based beverage, coffee beverage, carbonated beverage, functional beverage, fruit / vegetable-based beverage, dairy beverage, soy milk. Beverages, flavored water, etc. can be mentioned, but are not limited thereto.
- non-alcoholic beer in the present specification means a carbonated drink having a beer-like flavor, and is a non-fermented non-alcoholic type, which does not substantially contain alcohol.
- non-alcoholic beer does not exclude beverages containing a very small amount of alcohol that cannot be detected.
- composition of the present invention is a tea-based beverage
- it is preferably a black tea beverage or a sugar-free tea beverage.
- sugar-free tea beverages include green tea beverages, oolong tea beverages, barley tea beverages, brown rice tea beverages, pigeon barley tea beverages, and sugar-free black tea beverages.
- the coffee beverage may be either packaged coffee or liquid coffee.
- the form of the carbonated drink is preferably a cola soft drink, a clear carbonated drink, ginger ale, a fruit juice-based carbonated drink, a milk-containing carbonated drink, or a sugar-free carbonated drink.
- Functional beverages include sports drinks, energy drinks, health support beverages and pouch jelly beverages.
- fruit / vegetable-based beverages include 100% fruit juice beverages, fruit-containing beverages, low-fruit juice-containing soft drinks, fruit-containing fruit beverages, and fruit meat beverages.
- Milky beverages include milk, drink yogurt, lactic acid fermented beverages or dairy soft drinks, and soymilk beverages include soymilk or soybean beverages.
- Alcoholic beverages refer to beverages containing alcoholic ingredients. It may be chu-hi.
- the alcohol raw material include brewed liquor, distilled liquor, and mixed liquor.
- Examples of brewed liquor include wine and beer.
- Speaking of distilled liquor for example, spirits (for example, gin, wokka, lamb, tequila, new spirits, etc., and alcohol for raw materials, etc.), liqueurs, whiskeys (for example, whiskey, brandy, etc.), shochu, and the like can be mentioned.
- the alcoholic beverage may contain a detectable amount of alcohol, for example, 1% by volume or more, 2% by volume or more, 3% by volume or more, 4% by volume or more, 5% by volume or more of alcohol. ..
- processed foods include processed foods of cereals, seafood and meat (bread, noodles, tortillas, pasta, ham, bacon, sausages, kamaboko, fried tempura, hanpen, etc.).
- dairy products include butter, cheese, yogurt, gui and the like.
- confectionery include, but are not limited to, candy, jam, chewing gum, ice cream, snack confectionery, cookies, biscuits, cakes, wafers, confectionery bread, chocolate, Japanese confectionery, and the like.
- the oral compositions of the present invention also include fine granules, tablets, granules, powders, capsules (including soft capsules, hard capsules), chewables, syrups, mouthwashes, toothpastes, oral ointments, mouthwashes, It may be in the form of a pharmaceutical or non-pharmaceutical product such as a throat spray, or a naturally liquid diet in which the composition of the present invention is blended with proteins, sugars, fats, trace elements, vitamins, emulsifiers, fragrances, etc. It may be a processed form such as a digestive nutritional diet, a component nutritional diet, a drink, and an enteral nutritional supplement.
- the present invention contains the components (a) and (b), and the amount of the component (b) is less than the taste recognition threshold, such as a drug, a quasi drug, a natural liquid diet, a semi-digestive nutritional diet, and an ingredient.
- Oral products such as nutritional foods, drinks, and enteral nutritional supplements are also provided. Oral products are a general term for products that are introduced into the mouth regardless of ingestion. Further, the oral composition of the present invention may be packaged and sterilized.
- sweetness intensity means the intensity of sweetness exhibited by a substance.
- sweetness degree 1 the sweetness degree of glucose is 0.6 to 0.7 (median value 0.65).
- the oral composition of the present invention contains a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, and exhibits the sweetness of the sweetness intensity Xb by the components (a) and (b), and 0.1 ⁇ Xa ⁇ Xb.
- Xa of "sweetness intensity Xa" is more than 0.1 and 0.5 or less, more than 0.1 and 1.0 or less, more than 0.1 and 1.5 or less, more than 0.1 and 2.0 or less, more than 0.1 and 2.5 or less, 0.1 Exceeds 3.0 or less, 0.1 to 3.5 or less, 0.1 to 4.0 or less, 0.1 to 4.5 or less, 0.1 to 5.0 or less, 0.1 to 5.5 or less, 0.5 to 1.0, 0.5 to 1.5, 0.5-2.0, 0.5-2.5, 0.5-3.0, 0.5-3.5, 0.5-4.0, 0.5-4.5, 0.5-5.0, 0.5-5.5, 1.0-1.5, 1.0-2.0, 1.0-2.5, 1.0-3.0, 1.0-3.5, 1.0-4.0, 1.0-4.5, 1.0-5.0, 1.0-5.5, 1.5-2.0, 1.5-2.5, 1.5-3.0, 1.5-3.5, 1.5-4.0, 1.5-4.5, 1.5-5.0, 1.5- 5.5, 2.0-2.5, 2.0-3.0, 1.5-3.5
- Xa also exceeds 0.1 and 6.0 or less, 0.1 and 6.5 or less, 0.1 and 7.0 or less, 0.1 and 7.5 or less, 0.1 and 8.0 or less, 0.1 or more 8.5 or less, 0.1 or 9.0 or less, 0.1 or more and 9.5.
- 1.0-10.0 1.0-10.5, 1.0-11.0, 1.0-11.5, 1.0-12.0, 1.0- 13.0, 1.0-14.0, 1.0-15.0, 1.0-16.0, 1.0-17.0, 1.0-18.0, 1.5-6.0, 1.5-6.5, 1.5-7.0, 1.5-7.5, 1.5-8.0, 1.5-8.5, 1.5-9.0, 1.5-9.5, 1.5-10.0, 1.5-10.5, 1.5-11.0, 1.5-11.5, 1.5-12.0, 1.5-13.0, 1.5-14.0, 1.5-15.0, 1.5-16.0, 1.5-17.0, 1.5-18.0, 2.0- 8.0, 2.0-8.5, 2.0-9.0, 2.0-9.5, 2.0-10.0, 2.0-10.5, 2.0-11.0, 2.0-11.5, 2.0-12.0, 2.0-13.0, 2.0-14.0, 2.0-15.0, 2.0- 16.0, 2.0-17.0, 2.0-18.0, 2.5-8.0, 2.5-8.5, 2.5-9.0, 2.5-9.5, 2.5-10.0, 2.5-10.5, 2.5-11.0, 2.5-11.5, 2.5-12.0, 2.5-13.0, 2.5-14.0, 2.5-15.0, 2.5-16.0
- X1 is preferably 0.5 to 10.0, more preferably 1.5 to 9.0, and even more preferably 2.0 to 8.0. Further, in another aspect of the present invention, X1 is preferably 0.5 to 5.5, more preferably 1.0 to 5.5, and even more preferably 2.0 to 5.0.
- the amount equivalent to the sweetness intensity Xa of the high sweetness sweetener means the amount that exhibits the sweetness of the sweetness intensity Xa under the condition that the high sweetness sweetener is dissolved in water at 20 ° C. having the same volume as the oral composition of the present invention. ..
- the amount of good-quality, high-sweetness sweetener may be Pa ppm, where Pa ppm is an amount equivalent to the sweetness intensity Xa.
- Pa is about 20 to about 800, about 25 to about 800, about 30 to about 800, about 35 to about 800, about 40 to about 800, about 45 to about 800, about 50 to about 800, about 55 to About 800, about 20 to about 750, about 25 to about 750, about 30 to about 750, about 35 to about 750, about 40 to about 750, about 45 to about 750, about 50 to about 750, about 55 to about 750 , About 20 to about 700, about 25 to about 700, about 30 to about 700, about 35 to about 700, about 40 to about 700, about 45 to about 700, about 50 to about 700, about 55 to about 700, about 20 to about 650, about 25 to about 650, about 30 to about 650, about 35 to about 650, about 40 to about 650, about 45 to about 650, about 50 to about 650, about 55 to about 650, about 20 to
- Pa is also 1-1500, 1-1200, 5-1200, 1-1000, 5-1000, 10-1000, 1-900, 5-900, 10-900, 15-900, 20-900, 25- 900, 30-900, 35-900, 40-900, 45-900, 50-900, 55-900, 1-800, 5-800, 10-800, 15-800, 20-800, 25-800, 30-800, 35-800, 40-800, 45-800, 50-800, 55-800, 1-700, 5-700, 10-700, 15-700, 20-700, 25-700, 30- 700, 35-700, 40-700, 45-700, 50-700, 55-700, 1-600, 5-600, 10-600, 15-600, 20-600, 25-600, 30-600, 35-600, 40-600, 45-600, 50-600, 55-600, 1-550, 1-540, 1-530, 1-520, 1-510, 1-505, 1-500, 1- 495, 1-490, 5-550, 5-540, 5-530, 5-520, 5-510, 5-505, 5-500, 5-495
- Pa is also about 100 to about 500, about 100 to about 450, about 100 to about 400, about 100 to about 350, about 100 to about 300, about 100 to about 250, about 100 to about 200, about 150 to about 150. 500, about 150 to about 450, about 150 to about 400, about 150 to about 350, about 150 to about 300, about 150 to about 250, about 150 to about 200, about 200 to about 500, about 200 to about 450, It can take values of about 200 to about 400, about 200 to about 350, about 200 to about 300, and about 200 to about 250.
- Xb is not particularly limited as long as it is larger than Xa, but is 0.5 to 6.0, 0.5 to 6.5, 0.5 to 7.0, 0.5 to 7.5, 0.5 to 8.0, 0.5 to 8.5, 0.5 to 9.0, 0.5 to 9.5, 0.5 to 10.0, 0.5. ⁇ 10.5, 0.5 ⁇ 11.0, 0.5 ⁇ 11.5, 0.5 ⁇ 12.0, 0.5 ⁇ 13.0, 0.5 ⁇ 14.0, 0.5 ⁇ 15.0, 0.5 ⁇ 16.0, 0.5 ⁇ 17.0, 0.5 ⁇ 18.0, 1.0 ⁇ 6.0, 1.0 ⁇ 6.5, 1.0 ⁇ 7.0 , 1.0-7.5, 1.0-8.0, 1.0-8.5, 1.0-9.0, 1.
- Xb is also 4.0-18, 4.0-16, 4.0-15.5, 4.0-14, 4.5-18, 4.5-16, 4.5-15.5, 4.5-14, 5.0-18, 5.0-16, 5.0-15.5, 5.0- 14, 5.
- the oral composition of the present invention exhibits an enhanced sweetness. Whether or not the sweetness of the oral composition of the present invention is enhanced can be evaluated by a panel trained in terms of sensuality. Further, the sweetness intensity of the oral composition of the present invention is such that the standard oral composition (for example, a beverage) which serves as a reference for sweetness has a sweetness intensity of 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,
- the oral composition of the present invention is prepared by varying the sucrose concentration to 11, 12, 13, 14, 15 and the panelists compare the sweetness of the oral composition of the present invention with the sweetness of the reference oral composition. The sweetness of the composition can be measured.
- the standard oral composition for example, beverage having a sweetness intensity of 1, 2, ...
- sucrose 15 has a sucrose content of 1 g / 100 g, 2 g / 100 g, ... 15 as compared with the oral composition to which sucrose is not added.
- the reference oral composition having the closest sweetness to the oral composition of the present invention is selected, and the selected reference oral composition is selected.
- sucrose By adding sucrose to the product, it is adjusted to have the same sweetness as the oral composition of the present invention, and at that time, the oral composition of the present invention is based on the sucrose content contained in the adjusted reference oral composition. It is also possible to measure the sweetness intensity of a product.
- VAS method sweetness intensity assessment
- the evaluator defines the intensity of sweetness as "not sweet at all" at the lower end and "I can't think of anything sweeter than this" at the upper end. Evaluation is made by expressing the sweetness intensity felt at that time by the position on the straight line using a paper on which a vertical line representing the intensity is drawn.
- the sweetness intensity of the oral composition of the present invention is not particularly limited as long as it is acceptable as a food, and for example, the sweetness degree is 4.0 to 20, 4.0 to 15, 4.0 to 12.5, 4.0 to 10, 4.5. ⁇ 20, 4.5 ⁇ 15, 4.5 ⁇ 12.5, 4.5 ⁇ 10, 5.0 ⁇ 20, 5.0 ⁇ 15, 5.0 ⁇ 12.5, 5.0 ⁇ 10, 5.5 ⁇ 20, 5.5 ⁇ 15, 5.5 ⁇ 12.5, 5.5 ⁇ 10, 6.0 ⁇ 20, 6.0 ⁇ 15, 6.0 ⁇ 12.5, 6.0 ⁇ 10, 6.5 ⁇ 20, 6.5 ⁇ 15, 6.5 ⁇ 12.5, 6.5 ⁇ 10, 7.0 ⁇ 20, 7.0 ⁇ 15, 7.0 ⁇ 12.5, 7.0 ⁇ 10, 7.5 ⁇ 20, 7.5 ⁇ 15, 7.5 ⁇ 12.5, 7.5 ⁇ 10, 7.5 ⁇ 9, 7.5 ⁇ 8, 8.0 ⁇ 20, 8.0 ⁇ 20, 8.0 ⁇ 20, 8.0 ⁇ 15, 8.0 ⁇ 12, 8.0 ⁇ 15, 8.0 ⁇ 12.5, 8.0 ⁇ 10, 8.5 ⁇
- the energy (total energy amount) of the oral composition of the present invention is 0 to 50 Kcal / 100 ml, 0 to 45 Kcal / 100 ml, 0 to 40 Kcal / 100 ml, 0 to 35 Kcal / 100 ml, 0 to 30 Kcal / 100 ml, 0 to 0 depending on the embodiment.
- the energy (total energy amount, TE) of the oral composition of the present invention is 0 ⁇ TE ⁇ 50 Kcal / 100 ml, 0 ⁇ TE ⁇ 45 Kcal / 100 ml, depending on the embodiment (for example, an embodiment containing a caloric sweetener).
- Ingredients (a) and (b) can be combined arbitrarily. As shown in Examples described later, by adding the component (b) to the component (a), it is possible to obtain a sweetness intensity Xb higher than the sweetness intensity Xa of the component (a) alone. That is, the sweetness of the component (a) can be enhanced by the component (b). Therefore, while maintaining the same sweetness as the oral composition containing sucrose, the oral composition such as food should be produced without using high-calorie sucrose or while reducing the amount of sucrose used. Can be done. Therefore, it is possible to design new low-calorie sweet foods and the like.
- the ingredient (a) is a high-sweetness sweetener such as RebD or RebM, which is particularly excellent in taste, and an additional sweetening substance such as D-allulose or erythritol is used as an amino acid. Improves sweetness. If you want to adjust the calories of food to low calories instead of zero, you can also add caloric sweeteners such as sucrose, glucose, fructose, and sorbitol as additional sweeteners.
- caloric sweeteners such as sucrose, glucose, fructose, and sorbitol as additional sweeteners.
- sweetener (a) or "ingredient (a)"
- RebA rebaugioside A
- the good-tasting, high-sweetness sweetener may be naturally occurring in a plant or the like, or may be artificially produced (for example, bioconversion, chemical synthesis, etc.). However, it is preferably a naturally occurring sweetener.
- the term "naturally occurring" does not mean that the high-intensity sweetening substance contained in the oral composition of the present invention is a natural substance, as long as the same substance is naturally present.
- the high-sweetness sweetening substance contained in the oral composition of the present invention may be artificially produced (for example, by bioconversion or the like) (non-natural product).
- Non-limiting examples of the sweetener (a) include, for example, RebD, RebM, neohesperidin dihydrochalcone, glycyrrhizin, somatin, monerin, mogroside, rubusoside, curculin, mabinlin, blazene, pentadin, phyrosultin, hernanzultin, miraculin, Stevia rebaudiana plant-containing sweet ingredient, Siraitia grosvenorii plant-containing sweet ingredient, Glycyrrhiza glabra plant-containing sweet ingredient, Rubus suavissimus S. Lee plant-containing sweet ingredient, Hydrangea macrophylla var.
- the sweetener (a) does not contain the main components of stevia sweeteners such as RebA and stevioside.
- the sweetener (a) comprises RebD, RebM, mogroside (eg, mogroside V) or a combination thereof.
- the sweetener (a) comprises RebD, RebM, mogroside (eg, mogroside V), thaumatin or a combination thereof.
- a good-tasting, high-sweetness sweetener comprises RebD, RebM, mogroside V, Luo Han Guo extract and combinations thereof.
- Luo Han Guo extract as a sweetener is an extract of Luo Han Guo containing a sweet substance derived from Luo Han Guo, and is approved as a food additive in various countries including Japan and is commercially available.
- sweetening substance derived from Luo Han Guo include mogroside V, mogroside IV, 11-oxo-mogroside V, and siamenoside I.
- Mogroside V is one of the major mogroside glycosides contained in Luo Han Guo, and it has been reported that it exhibits high-quality sweetness characteristics close to those of sucrose as compared with rebaugioside A.
- the Luo Han Guo extract preferably contains mogloside V, the proportion of which is not limited, but is 10% by weight or more, 15% by weight or more, 20% by weight or more, 25% by weight or more, 30% by weight of the total dry weight of the Luo Han Guo extract. By weight% or more, 35% by weight or more, 40% by weight or more, 45% by weight or more, 50% by weight or more, 55% by weight or more, 60% by weight or more, 65% by weight or more, 70% by weight or more, 75% by weight or more, etc. It may be there.
- the content of mogroside V can be determined by a known method, such as liquid chromatography.
- the Rakan fruit extract is obtained by using the fruit of Rakan fruit (Siraitia grosvenorii) as an appropriate solvent (for example, an aqueous solvent such as water, an alcohol solvent such as ethanol and methanol, a mixed solvent of an aqueous solvent such as hydrous ethanol and hydrous methanol, and an alcohol solvent. Etc.), and then optionally degreasing, purification, concentration, drying and the like.
- an appropriate solvent for example, an aqueous solvent such as water, an alcohol solvent such as ethanol and methanol, a mixed solvent of an aqueous solvent such as hydrous ethanol and hydrous methanol, and an alcohol solvent. Etc.
- sweetener contains an amount equivalent to sweetness intensity Xa as described above.
- sweetness intensity of sucrose per unit concentration Brix 1 is defined as sweetness 1
- the sweetness of rebaugioside D is about 225
- the sweetness of rebaugioside M is about 230
- the sweetness of rebaugioside B is about 325
- the sweetness of rebaugioside N is about 325.
- the degree is 200 to 250 (center value 225)
- the sweetness of rebaugioside O is 200 to 250 (center value 225)
- the sweetness of rebaugioside E is 70 to 80 (center value 75)
- Luo Han Guo extract containing 40% MogV
- the sweetness is about 130, the sweetness of mogroside V is about 270, and the sweetness of thaumatin is 2,000.
- Good taste High sweetness
- the value obtained by multiplying these sweetnesses by the concentration of the high sweetness sweetener (w / v% (in the case of beverages, it can be equated with w / w%)) is the good taste quality.
- High sweetness The sweetness intensity of the sweetener.
- the sweetener (a) comprises the following combinations: RebD and RebM, RebD and mogroside V, RebM and mogroside V, RebD and RebM and mogroside V, RebD and neohesperidin dihydrochalcone, RebM and neohesperidin.
- the sweetener (a) comprises the following combinations: RebD and thaumatin, RebM and thaumatin, mogroside V and thaumatin, RebD and RebM and thaumatin, RebD and mogroside V and thaumatin, RebM and mogroside V and thaumatin, RebD, RebM, mogroside V and thaumatin.
- the amount of the sweetening agent (a) contained in the oral composition in one aspect of the present invention is an amount obtained by combining all the sweetening substances.
- the amount of sweetener (a) is Pa (ppm)
- Pa is, for example, about 20 to about 800, about 25 to about 800, about 30 to about 800, about 35 to about 800, about 40 to about 800, About 45 to about 800, about 50 to about 800, about 55 to about 800, about 20 to about 750, about 25 to about 750, about 30 to about 750, about 35 to about 750, about 40 to about 750, about 45 ⁇ About 750, about 50 ⁇ about 750, about 55 ⁇ about 750, about 20 ⁇ about 700, about 25 ⁇ about 700, about 30 ⁇ about 700, about 35 ⁇ about 700, about 40 ⁇ about 700, about 45 ⁇ about 700, about 50 to about 700, about 55 to about 700, about 20 to about 650, about 25 to about.
- amino acid or its derivative or its salt The amino acid or amino acid salt used in the present invention is not particularly limited as long as it is an organic compound having both functional groups of an amino group and a carboxyl group or a salt thereof and which has an effect of increasing sweetness.
- proline and hydroxyproline in which hydrogen of an amino group replaces a side chain portion in the molecule to form a cyclic structure are also included in amino acids in the present specification.
- the amino acid derivative used in the present invention also includes a derivative having no carboxyl group such as taurine.
- the amino acid used in the present invention may be D-form, L-form, or racemic-form (also referred to as DL amino acid in the present specification) composed of D-form and L-form.
- the amino acid can be selected from neutral amino acids, basic amino acids and acidic amino acids.
- Neutral amino acids include glycine, alanine, valine, isoleucine, leucine, etc. having an alkyl group, serine, threonine, etc. having an OH group (hydroxy group), tyrosine, phenylalanine, tryptophan, etc. having an aromatic group (or aromatic ring), etc.
- Metionine having a sulfur-containing group, cysteine and the like, proline having an imino group, hydroxyproline and the like, glutamine having an amide group, asparagine and the like can be preferably selected.
- As the basic amino acid arginine, lysine, histidine and the like can be preferably selected.
- the acidic amino acid can be preferably selected from glutamic acid, aspartic acid and the like. In a preferred embodiment of the invention, the amino acid is selected from neutral or basic amino acids.
- the amino acid comprises a basic amino acid or a neutral amino acid, which is selected from amino acids having an alkyl group, an OH group, a sulfur-containing group or an imino group in the side chain, and a combination thereof.
- the neutral amino acids those having an alkyl group in the side chain include, for example, glycine, alanine, valine, isoleucine and leucine, and those having an OH group in the side chain include, for example, serine and threonine.
- Examples of those having an imino group in the side chain include proline and hydroxyproline.
- the amino acid contained in the oral composition in one aspect of the present invention is one or more of the 22 amino acids that form a protein. Specifically, ala, arginine (Arg), aspartic acid (Asn), aspartic acid (Asp), cysteine (Cys), glutamine (Gln), glutamic acid (Glu), glycine (Gly), histidine (His).
- Isoleucine Ile
- Leucine Leu
- Lysine Lys
- Methionine Met
- Phenylalanine Phe
- Proline Proline
- Serin Ser
- Threonine Threonine
- Trp Tryptophan
- Tyrosine Examples include the L-forms of (Tyr), valine (Val), selenocysteine (Sec) and pyrrolicin (Pyl).
- the amino acid contained in the oral composition in one aspect of the present invention is one or more of the 22 amino acids forming a protein.
- the amino acid contained in the oral composition according to one aspect of the present invention is one or more selected from amino acids having a molecular weight of 70 to 260.
- amino acids include alanine (molecular weight: 89), arginine (molecular weight: 174), asparagine (molecular weight: 132), aspartic acid (molecular weight: 133), cysteine (molecular weight: 121), glutamine (molecular weight: 146), Glutamic acid (molecular weight: 147), glycine (molecular weight: 75), histidine (molecular weight: 155), isoleucine (molecular weight: 131), leucine (molecular weight: 131), lysine (molecular weight: 146), methionine (molecular weight: 149), phenylalanine (Molecular weight: 165), Proline (Molecular weight: 115), Serine (Molecular weight: 105), Threonine (Molecular weight: 119), Tryptophan (Molecular
- the amino acid is one or more selected from amino acids having a molecular weight of 75 to 204, more preferably one or more selected from amino acids having a molecular weight of 75 to 174, and further preferably having a molecular weight. Is one or more selected from 75 to 146 amino acids.
- the amino acid or salt thereof is L-Asparagine, L-Aspartic acid, Monosodium L-Aspartate, DL-Alanine, DL-Alanine, L-Alanine, L-Alanine solution, L-Arginine, L-Arginine L-glutamate, L-glutamate (L) -Glutamine), L-Cystine, L-Cystein Hydrochloride, L-Serine, L-Tyrosine, L-Glutamic Acid Acid, L-Glutamic acid ammonium (Monoammonium L-Glutamate), L-Glutamic acid potassium (Monopotassium L-Glutamate), L-Glutamic acid calcium (Monocalcium Di-L-Glutamate), L-Glutamic acid sodium (also known as sodium glutamate) (Monosodium L) -Glutamate), magnesium L-glutamate (Monomagnesium Di-L-Glutamate),
- amino acids include amino acids selected from glycine, alanine, valine, isoleucine, leucine, serine, threonine, glutamine, asparagine, arginine, lysine, histidine and combinations thereof.
- the amino acid threshold means a detection threshold or a taste recognition threshold.
- the detection threshold means the minimum concentration at which the difference from water can be clearly shown, but the type of taste (eg, bitterness, acidity, sweetness, etc.) does not necessarily have to be recognized.
- the taste cognitive threshold means the minimum concentration at which taste can be recognized (for example, Eur J Clin Nutr (2004) 58, 629-636).
- Amino acid thresholds are summarized in Susan S. Schiffman et al., “Comparison of Taste Qualities and Thresholds of D-and L-Amino Acids”, Physiology & Behavior, Vol. 27, pp. 51-59 (1981). ing.
- the detection thresholds for each amino acid are: glycine (30.9mM), L-threonine (25.7mM), L-serine (20.9mM), L-alanine (16.2mM), L-proline (15.1mM). ), L-Glutamine (9.77mM), L-Isoleucine (7.41mM), L-Phenylalanine (6.61mM), L-Leucine (6.45mM), L-valine (4.16mM), L-Methionine (3.72mM), L-tryptophane (2.29mM), L-aspartin (1.62mM), L-histidine (1.23mM), L-arginine (1.20mM), L-lycine (0.708mM), L-aspartic acid (0.182mM), L -Glutamic acid (0.063mM), L-cysteine (0.063mM).
- the taste recognition threshold is about 1.5 to 2 times the detection threshold (Yuki Yamauchi et al., "Whole Oral Taste Test (1st Report) -Basic Examination and Main Principle Analysis-” , Japan Otolaryngology Society Bulletin Vol. 98 (1995) No. 1, p.119-129, and Reiko Omori, "Comparison of Taste Sensitivity Between Generations", Utsunomiya University Faculty of Education Bulletin, Part 1 (2013) Vol.63 p.201-210)).
- an actually measured value as the taste recognition threshold value of an amino acid.
- the taste recognition threshold value of an amino acid can be obtained by a sensory test in which an amino acid-containing aqueous solution is prepared at a plurality of concentration levels, tasted in order from the one with the lowest concentration to the one with the highest concentration, and whether or not the taste is felt.
- the concentration at which it is detected to be different from water is defined as the detection threshold, and the concentration at which taste is recognized is defined as the cognitive threshold.
- an amino acid that already has a theoretical value (literature value) can be determined by preparing aqueous solutions having a plurality of concentration levels near the concentration and testing by a plurality of persons trained in sensory.
- the detection threshold described in the literature is 16.2 mM
- the theoretical cognitive threshold calculated from the detection threshold is 32.4 mM, so 5 mM, 10 mM, 15 mM, 20 mM, 25 mM, 30 mM.
- the cognitive threshold can be measured by performing a sensory test with multiple levels of aqueous solution selected from and 35 mM.
- the oral composition comprises glycine and the glycine content is greater than 0 mM and less than 80 mM, less than 75 mM, less than 70 mM, 65 mM or less, mM 60 mM or less, 55 mM or less, 50 mM or less, 45 mM or less, 40 mM or less, It may be 35 mM or less, 30 mM or less, 25 mM or less, 20 mM or less, 15 mM or less, or 10 mM or less.
- 60mM to 70mM 10mM to 60mM, 20mM to 60mM, 30mM to 60mM, 40mM to 60mM, 50mM to 60mM, 10mM to 50mM, 20mM to 50mM, 30mM to 50mM, 40mM to 50mM, 10mM to 40mM, 20mM to 40mM It may be 40 mM, 10 mM to 30 mM, 20 mM to 30 mM.
- the oral composition may contain alanine and the alanine content may be greater than 0 mM and less than 32.4 mM, less than 30 mM, less than 25 mM, less than 20 mM, less than 15 mM or less than 10 mM.
- the oral composition comprises valine and the valine content is greater than 0 mM and less than 50 mM, less than 45 mM, less than 40 mM, less than 35 mM, less than 30 mM, less than 25 mM, less than 20 mM, less than 15 mM or less than 10 mM. There may be.
- Valine may be L-form, D-form or racemic (DL-form), but is preferably L-form.
- the oral composition may contain isoleucine, and the content of isoleucine may be more than 0 mM and 25 mM or less, 20 mM or less, 15 mM or less, 10 mM or less, 5 mM or less.
- Isoleucine may be L-form, D-form or racemic (DL-form), but is preferably L-form.
- the oral composition comprises leucine and the leucine content is greater than 0 mM and less than 15 mM, less than 13 mM, less than 12 mM, 11 mM or less, 10 mM or less, 9 mM or less, 8 mM or less, 7 mM or less, 6 mM or less, It may be 5 mM or less, 4 mM or less, 3 mM or less, 2 mM or less, and 1 mM or less.
- Leucine may be L-form, D-form or racemic (DL-form), but is preferably L-form.
- the oral composition may contain leucine and the leucine content may be more than 0 mM and less than 50 mM, less than 45 mM, less than 40 mM, 35 mM or less, 30 mM or less, 25 mM or less, 20 mM or less.
- the oral composition comprises serine and the serin content is greater than 0 mM and less than 130 mM, less than 100 mM, less than 80 mM, less than 50 mM, less than 45 mM, less than 40 mM, less than 35 mM, less than 30 mM, less than 25 mM, It may be 20 mM or less, 15 mM or less, or 10 mM or less.
- 10mM to 130mM 10mM to 100mM, 10mM to 80mM, 20mM to 80mM, 30mM to 80mM, 40mM to 80mM, 50mM to 80mM, 60mM to 80mM, 70mM to 80mM, 10mM to 70mM, 20mM to 70mM, 30mM to 70mM.
- 40mM to 70mM 50mM to 70mM, 60mM to 70mM, 10mM to 60mM, 20mM to 60mM, 30mM to 60mM, 40mM to 60mM, 50mM to 60mM, 10mM to 50mM, 20mM to 50mM, 30mM to 50mM, 40mM to 50mM, 40mM to 50mM 40mM, 20mM to 40mM, 30mM to 40mM, 10mM to 30mM, 20mM to 30mM, 5mM to 45mM, 5mM to 40mM, 5mM to 35mM, 5mM to 30mM, 5mM to 25mM, 5mM to 20mM, 5mM to 15mM, 5mM to 5mM It may be 1 mM to 45 mM, 1 mM to 40 mM, 1 mM to 35 mM, 1 mM to 30 mM, 1 mM to 25mM, 5
- the oral composition comprises threonine and the threonine content is greater than 0 mM and less than 70 mM, less than 65 mM, 60 mM or less, 55 mM or less, 50 mM or less, 45 mM or less, 40 mM or less, 35 mM or less, 30 mM or less, It may be 25 mM or less, 20 mM or less, 15 mM or less, or 10 mM or less.
- 1mM to 70mM 1mM to 65mM, 1mM to 60mM, 1mM to 55mM, 1mM to 50mM, 5mM to 50mM, 10mM to 50mM, 15mM to 50mM, 20mM to 50mM, 25mM to 50mM, 1mM to 50mM, 5mM to 50mM.
- the oral composition comprises phenylalanine and the content of phenylalanine is greater than 0 mM and less than 15 mM, less than 13 mM, 12 mM or less, 11 mM or less, 10 mM or less, 9 mM or less, 8 mM or less, 7 mM or less, 6 mM or less, It may be 5 mM or less, 4 mM or less, 3 mM or less, 2 mM or less, 1 mM or less.
- the oral composition may contain tryptophan, and the tryptophan content may be more than 0 mM and 5 mM or less, 4 mM or less, 3 mM or less, 2 mM or less, and 1 mM or less. Alternatively, it may be 1 mM to 5 mM, 2 mM to 5 mM, 3 mM to 5 mM, 4 mM to 5 mM. Tryptophan may be L-form, D-form or racemic (DL-form), but is preferably L-form.
- the oral composition comprises methionine and the methionine content is greater than 0 mM and less than 10 mM, 9 mM or less, 8 mM or less, 7 mM or less, 6 mM or less, 5 mM or less, 4 mM or less, 3 mM or less, 2 mM or less, It may be 1 mM or less.
- Methionine may be L-form, D-form or racemic-form (DL-form), but is preferably L-form.
- the oral composition comprises proline and the proline content is greater than 0 mM and less than 120 mM, less than 100 mM, less than 80 mM, less than 50 mM, less than 45 mM, less than 40 mM, less than 35 mM, less than 30 mM, less than 25 mM, It may be 20 mM or less, 15 mM or less, or 10 mM or less.
- 10mM to 120mM 10mM to 100mM, 10mM to 80mM, 20mM to 80mM, 30mM to 80mM, 40mM to 80mM, 50mM to 80mM, 60mM to 80mM, 70mM to 80mM, 10mM to 70mM, 20mM to 70mM, 30mM to 70mM.
- 40mM to 70mM 50mM to 70mM, 60mM to 70mM, 10mM to 60mM, 20mM to 60mM, 30mM to 60mM, 40mM to 60mM, 50mM to 60mM, 10mM to 50mM, 20mM to 50mM, 30mM to 50mM, 40mM to 50mM, 40mM to 50mM It may be 40 mM, 20 mM to 40 mM, 30 mM to 40 mM, 1 mM to 30 mM, 5 mM to 30 mM, 10 mM to 30 mM, 15 mM to 30 mM, 20 mM to 30 mM, 25 mM to 30 mM.
- Proline may be L-form, D-form or racemic (DL-form), but is preferably L-form.
- the oral composition comprises glutamine and the glutamine content is greater than 0 mM and less than 20 mM, 19 mM or less, 18 mM or less, 17 mM or less, 16 mM or less, 15 mM or less, 14 mM or less, 13 mM or less, 12 mM or less, It may be 11 mM or less, 10 mM or less, 9 mM or less, 8 mM or less, 7 mM or less, 6 mM or less, 5 mM or less, 4 mM or less, 3 mM or less, 2 mM or less, 1 mM or less.
- the oral composition comprises asparagine and the asparagine content is greater than 0 mM and less than 20 mM, 19 mM or less, 18 mM or less, 17 mM or less, 16 mM or less, 15 mM or less, 14 mM or less, 13 mM or less, 12 mM or less, It may be 11 mM or less, 10 mM or less, 9 mM or less, 8 mM or less, 7 mM or less, 6 mM or less, 5 mM or less, 4 mM or less, 5 mM or less, 2 mM or less, 1 mM or less.
- the oral composition comprises arginine, and the content of arginine is more than 0 mM and less than 4.0 mM, 3.5 mM or less, 3.0 mM or less, 2.5 mM or less, 2.0 mM or less, 1.5 mM or less, 1.0 mM or less. , 0.5 mM or less.
- Arginine may be L-form, D-form or racemic-form (DL-form), but is preferably L-form.
- the oral composition contains lysine and the lysine content is greater than 0 mM and less than 3.0 mM, less than 2.5 mM, less than 2.0 mM, less than 1.5 mM, less than 1.0 mM, less than 0.5 mM. Good.
- Lysine may be L-form, D-form or racemic (DL-form), but is preferably L-form.
- the oral composition comprises lysine hydrochloride and the content of lysine hydrochloride is greater than 0 mM and less than 1.0 mM, less than 0.9 mM, less than 0.8 mM, less than 0.7 mM, less than 0.6 mM, less than 0.5 mM. , 0.4 mM or less, 0.3 mM or less, 0.2 mM or less.
- the oral composition comprises histidine and the histidine content is greater than 0 mM and less than 4.0 mM, less than 3.5 mM, 3.0 mM or less, 2.5 mM or less, 2.0 mM or less, 1.5 mM or less, 1.0 mM or less. , 0.5 mM or less.
- the histidine may be L-form, D-form or racemic (DL-form), but is preferably L-form.
- the oral composition comprises glutamate and the content of glutamate is greater than 0 mM and less than 0.40 mM, less than 0.35 mM, less than 0.30 mM, less than 0.25 mM, 0.20 mM or less, 0.15 mM or less, 0.14 mM or less. , 0.13mM or less, 0.12mM or less, 0.11mM or less, 0.10mM or less, 0.09mM or less, 0.08mM or less, 0.07mM or less, 0.06mM or less, 0.05mM or less, 0.04mM or less, 0.03mM or less, 0.02mM or less, 0 . It may be 01 mM or less.
- the oral composition comprises aspartic acid, and the content of aspartic acid is more than 0 mM and 1.5 mM or less, 1.4 mM or less, 1.3 mM or less, 1.2 mM or less, 1.1 mM or less, 1.0 mM or less, 0.9. It may be mM or less, 0.8 mM or less, 0.7 mM or less, 0.6 mM or less, 0.5 mM or less, 0.4 mM or less, 0.3 mM or less, 0.2 mM or less, 0.1 mM or less.
- the oral composition according to one aspect of the present invention does not contain sodium aspartate as an amino acid salt.
- the oral composition of the present invention may contain a sweetener in addition to the good-tasting, high-sweetness sweetener of the component (a).
- sweetener means any substance or group of substances that causes a sweetening response.
- the sweetener can be divided into a sugar-based sweetening agent and a non-sugar-based sweetening agent according to the structural characteristics, and can be divided into a low-sweetness sweetening agent and a high-sweetness sweetening agent based on the sweetness degree. It is also possible to divide sweet substances into caloric sweeteners and non-caloric sweeteners based on energy (calories). Among the following sweeteners, those classified as good-quality, high-sweetness sweeteners shall be included in the component (a).
- Sugar-based sweeteners are not limited to sugar alcohols such as sucrose, lactose, glucose, malt sugar, water candy, isomerized sugar, fructose and other starch sugars, erythritol, sorbitol, mannitol, maltitol, xylitol and palatinit. , Sucrose, palatinose, fructose oligosaccharide, coupling sugar (R) , lactose, galactose oligosaccharide, milk fruit oligosaccharide, raffinose, soybean oligosaccharide, honey and the like. In addition, sugar-based sweeteners contain rare sugars.
- Rare sugar refers to monosaccharides and their derivatives whose abundance is small in nature. For example, naturally occurring aldoses other than D-glucose, D-galactose, D-mannose, D-ribose, D-xylose and L-arabinose, naturally occurring ketose other than D-fractose, natural other than D-sorbitol.
- the sugar alcohols and the like present in the rare sugars are included in the rare sugars.
- Non-limiting examples of rare sugars include, for example, D-tagatose, D-sorbose, D-alloth (D-psicose), L-flactose, L-allulose (L-psicose), L-tagatose, L-sorbose, etc.
- Examples thereof include aldoses such as ketose, altrose and D-allose, and sugar alcohols such as xylitol, erythritol and D-talitol.
- Non-sugar sweeteners include, but are not limited to, steviol glycosides, glycyrrhizin, monellin, thaumatin, aspartame, saccharin, sodium saccharin, disodium glycyrrhizinate, trisodium glycyrrhizinate, acesulfam K, neohesperidin dihydrocalcone, sucralose And so on.
- the low-sweetness sweetener means a compound having the same sweetness as sucrose (for example, about 0.1 to 2 times, about 0.5 to 1.5 times, etc. of sucrose).
- Non-limiting examples of low sweetness sweeteners include sucrose, high fructose corn syrup, glucose, fructose, lactose, malt sugar, xylose, lactulose, fructo-oligosaccharide, maltooligosaccharide, isomaltooligosaccharide, galactooligosaccharide, and coupling sugar (R).
- Sugar low sweetness sweeteners such as palatinose, sugar alcohol low sweetness sweeteners such as multitor, sorbitol, erythritol, xylitol, lactitol, palatinit, reduced starch saccharified product and the like.
- the low-sweetness sweetener contains a rare sugar.
- High-sweetness sweetener means a compound having a stronger sweetness than sucrose, and includes a naturally-derived compound, a synthetic compound, or a combination of a naturally-derived compound and a synthetic compound.
- High-sweetness sweetener is 5 times or more, 10 times or more, 50 times or more, 100 times or more, 500 times or more, 1000 times or more, 5000 times or more, 10000 times or more, 50,000 times more than sucrose in the same amount as sucrose. As mentioned above, it exhibits a sweetness of 100,000 times or more.
- high-sweetness sweeteners include peptide-based sweeteners such as aspartame, neotheme, and advantheme, for example, sucrose derivatives such as sucralose, such as acesurfam K, saccharin, sodium saccharin, sodium cyclamate, dultin, and diglycyrrhizinate.
- Synthetic sweeteners such as sodium, trisodium glycyrrhizinate, neohesperidin dihydrochalcone (including naturally occurring but predominantly synthetic products such as neohesperidine dihydrochalcone), such as somatin and monerin.
- Thunberg Extracts Thaumataococcus daniellii Benth extract, Dioscoreophyllum volkensii extract, Curculigo latifolia extract, Richadella dulcifica extract, Richadella dulcifica extract, Pentadiplandra ni pariseana Masaikai extract, Lippia dulcis extract, etc. and sweet components in the extract, such as stevia extract and stevia derivatives such as enzyme-treated stevia, which is obtained by enzymatically treating stevia and adding glucose.
- Glycyrrhiza glabra Plant-containing sweetening ingredients (eg, triterpene such as glycyrrhizin), sugars obtained from plant extracts such as steviol sugar, mogloside obtained by processing Luo Han Guo and Luo Han Guo extract Sugar), Rubus suavissimus S. Lee Plant-containing sweet components (eg, diterpen sugars such as rubusoside), Hydrangea macrophylla var.
- Thunbergii Plant-containing sweet components eg, dihydroisocoumarin such as phyrosultin), Sclerochitons ilicifolius Plant-containing sweet components (eg, monatin, etc.) Amino acids), Thaumataococcus daniellii Benth plant-containing sweet components (eg, proteins such as somatin), Dioscoreophyllum volkensii plant-containing sweet components (eg, proteins such as monerin), Curculigo latifolia plant-containing sweet components (eg, proteins such as curculin), Richadella dulcifica plant-containing sweet components (eg, proteins such as miraculin), Pentadiplandra brazzeana plant-containing sweet components (eg, proteins such as brazein and pentadin), Capparis masaikai plant-containing sweet components (eg, proteins such as mabinlin), Lippia dulcis plant-containing Examples include sweetening components (eg, sesquiterpenes such as hern
- steviol glycosides examples include stevioside, rebaudioside A (hereinafter, rebaudioside may be abbreviated as Reb), RebB, RebC, RebD, RebM, RebN, RebO, zulucoside A, and rubusoside.
- mogroside examples include mogroside IV and mogroside V.
- the licorice extract refers to a glycyrrhizic acid-based extract obtained from the roots or rhizomes of Glycyrrhiza uralensis, Glycyrrhiza chinensis or Licorice liquorice.
- licorice extract examples include licorice extract, glycyrrhizin, and licorice extract.
- the sucrose derivative includes, for example, one obtained by substituting the OH group or H group of sucrose with another substituent, and examples thereof include a halogen derivative of sucrose (sclarose) and an oxathiadinone dioxide derivative. , Sugar alcohol, aldonic acid, uronic acid and the like.
- Caloric sweetener typically means a sweetening substance with an energy of 4 kcal / g. Whether the energy of the sweet substance is known, the content is measured by HPLC etc. and calculated by multiplying by the energy conversion coefficient, or the physical heat of combustion is measured by a calorimeter (for example, bomb calorimeter etc.). Can be determined by correcting with the digestion and absorption rate, the amount of heat excreted, and the like.
- caloric sweeteners include, for example, sucrose, lactose, glucose, maltose, starch syrup, high fructose corn syrup, fructose, and the like.
- Non-caloric sweeteners typically refer to those that are difficult to digest in the body and result in less energy being taken in, less than 2 kcal / g, preferably less than 1 kcal / g, more preferably. It means a sweetening substance having an energy of less than 0.5 kcal / g.
- Non-limiting examples of non-caloric sweeteners include, for example, non-caloric hexoses such as allose (psicose) and allose, non-caloric pentoses such as xylose and arabinose, non-caloric tetrose such as erythrose and treose, erythritol and alitor Non-caloric sugar alcohols such as, etc. may be mentioned.
- sweet substances can be classified by energy (calorie) level.
- sweet substances can be classified into sweet substances having an energy of 4 kcal / g or more and sweet substances having an energy of less than 4 kcal / g.
- Sweet substances with energy less than 4 kcal / g are also sweet substances with energy less than 3 kcal / g, sweet substances with energy less than 2.5 kcal / g, sweet substances with energy less than 2 kcal / g, 1.5 kcal / Sweet substance with energy less than g, sweet substance with energy less than 1 kcal / g, sweet substance with energy less than 0.5 kcal / g, sweet substance with energy more than 1 kcal / g and less than 4 kcal / g, 2 kcal / Sweet substance with energy of g or more and less than 4 kcal / g, sweet substance with energy of 3 kcal / g or more and less than 4 kcal / g, sweet substance with energy of 2 kcal /
- Sucrose, lactose, glucose, maltose, water candy, isomerized sugar, fructose, etc. are sweet substances having an energy of 4 kcal / g or more
- sorbitol is a sweet substance having an energy of 2 kcal / g or more and less than 4 kcal / g.
- Xylitol, D-xylose, D-ribose, D-tagatose, arabinose, etc. are sweet substances having energy of 0 kcal / g or more and less than 2 kcal / g as D-allulose, erythritol, allose, erythrose, treose, alitor. And so on.
- the oral composition in one embodiment of the present invention comprises a low sweetness sweetener.
- the following oral composition (hereinafter, also referred to as the oral composition of aspect A) is provided.
- the oral composition according to one aspect of the present invention sweetens components other than (a) a good-quality high-sweetness sweetener in an amount equivalent to a sweetness intensity Xa and (c) a low-sweetness sweetener in an amount equivalent to a sweetness intensity Xc. Not included as a fee.
- the low sweetness sweetener comprises a sweetener selected from hexose, pentose, tetrose, a polysaccharide having an aldose or ketose terminal sugar, a sugar alcohol and a combination thereof.
- the low sweetness sweetener is selected from glucose, sucrose, fructose, maltose, oligosaccharides, high fructose corn syrup, lactose, psicose, allose, tagatose, xylose, ribose and combinations thereof. including.
- Xc of "sweetness intensity Xc" is 0 to 0.5, 0 to 1.0, 0 to 1.5, 0 to 2.0, 0 to 2.5, 0 to 3.0, 0 to 3.5, 0 to 4.0, 0 to 4.5, 0 to 5.0, 0 to 5.5, 0-6.0, 0-6.5, 0-7.0, 0-7.5, 0-8.0, 0-8.25, 0-8.5, 0-8.75, 0-9.0, 0-9.25, 0-9.5, 0-9.75, 0 to 10.0, 0.05 to 0.5, 0.05 to 1.0, 0.05 to 1.5, 0.05 to 2.0, 0.05 to 2.5, 0.05 to 3.0, 0.05 to 3.5, 0.05 to 4.0, 0.05 to 4.5, 0.05 to 5.0, 0.05 to 5.5, 0.05 to 6.0, 0.05-6.5, 0.05-7.0, 0.05-7.5, 0.05-8.0, 0.05-8.25, 0.05-8.5, 0.05-8.75, 0.05-9.0, 0.05-9.25
- Xc is also 0 to 10.5, 0 to 11.0, 0 to 11.5, 0 to 12.0, 0 to 12.5, 0 to 13.0, 0 to 13.5, 0 to 14.0, 0 to 14.5, 0 to 15.0, 0.05 to 10.5, 0.05 to 11.0, 0.05-11.5, 0.05-12.0, 0.05-12.5, 0.05-13.0, 0.05-13.5, 0.05-14.0, 0.05-14.5, 0.05-15.0, 0.1-10.5, 0.1-11.0, 0.1-11.5, 0.1-12.0, 0.1 to 12.5, 0.1 to 13.0, 0.1 to 13.5, 0.1 to 14.0, 0.1 to 14.5, 0.1 to 15.0, 0.5 to 10.5, 0.5 to 11.0, 0.5 to 11.5, 0.5 to 12.0, 0.5 to 12.5, 0.5 to 13.0, 0.5 to 13.5, 0.5-14.0, 0.5-14.5, 0.5-15.0, 1.0-10.5, 1.0-11.0, 1.0-11.5, 1.0-12.0, 1.0-12.5, 1.0-13.0, 1.0
- the amount equivalent to the sweetness intensity Xc of the low sweetness sweetener is the amount (concentration) that exhibits the sweetness of the low sweetness intensity Xc under the condition that the low sweetness sweetener is dissolved in water at 20 ° C. having the same volume as the oral composition of the present invention. ).
- Xd is not particularly limited as long as it is larger than Xa + Xc, but 4.0 to 20, 4.0 to 15, 4.0 to 12.5, 4.0 to 10, 4.5 to 20, 4.5 to 15, 4.5 to 12.5, 4.5 to 10, 5.0.
- ⁇ 20 5.0 ⁇ 15, 5.0 ⁇ 12.5, 5.0 ⁇ 10, 5.5 ⁇ 20, 5.5 ⁇ 15, 5.5 ⁇ 12.5, 5.5 ⁇ 10, 6.0 ⁇ 20, 6.0 ⁇ 15, 6.0 ⁇ 12.5, 6.0 ⁇ 10, 6.5 ⁇ 20 , 6.5-15, 6.5-12.5, 6.5-10, 7.0-20, 7.0-15, 7.0-12.5, 7.0-10, 7.5-20, 7.5-15, 7.5-12.5, 7.5-10, 7.5-9, 7.5 ⁇ 8, 8.0 ⁇ 20, 8.0 ⁇ 20, 8.0 ⁇ 15, 8.0 ⁇ 12.5, 8.0 ⁇ 10, 8.5 ⁇ 20, 8.5 ⁇ 15, 8.5 ⁇ 12.5, 8.5 ⁇ 10, 9.0 ⁇ 20, 9.0 ⁇ 12, 9.0 ⁇ 12, 9.5
- X3 is also 4.0-18, 4.0-16, 4.0-15.5, 4.0-14, 4.5-18, 4.5-16, 4.5-15.5, 4.5-14, 5.0-18, 5.0-16, 5.0-15.5, 5.0-14, 5.5-18, 5.5-16, 5.5-15.5, 5.5-14, 6.0-18, 6.0-16, 6.0-15.5, 6.0-14, 6.5-18, 6.5-16, 6.5-15.5, 6.5- 14, 7.0-18, 7.0-16, 7.0-15.5, 7.0-14, 7.5-18, 7.5-16, 7.5-15.5, 7.5-14, 7.5-9, 7.5-8, 8.0-18, 8.0- 18, 8.0-16, 8.0-15.5, 8.0-14, 8.5-18, 8.5-16, 8.5-15.5, 8.5-14, 9.0-18, 9.0-16, 9.0-15.5, 9.0-14, 9.5-18, It may be 9.5 to 16, 9.5 to 15.5, 9.5 to 14, 10.0 to 18, 10.0 to 16, 10.0 to 15.5, 10.5 to 18, 10.5 to 16, 10.5 to 15.5.
- the oral composition of the present invention contains an antioxidant (sodium erythorbate, etc.), an emulsifier (sucrose fatty acid ester, sorbitan fatty acid ester, polyglycerin fatty acid ester, etc.), an acidulant, and a fragrance, as long as the effects of the present invention are not impaired. Etc. can be appropriately blended.
- It contains (a) a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, and (b) an amino acid below the taste recognition threshold or a derivative thereof or a salt thereof.
- the components (a) and (b) exhibit sweetness with a sweetness intensity of Xb, and 0.1 ⁇ Xa ⁇ Xb.
- the good-tasting, high-sweetness sweetener is selected from a high-sweetness sweetener selected from rebaugioside D, rebaugioside M, mogroside V, Luo Han Guo extract and combinations thereof, preferably rebaugioside D, rebaugioside M and combinations thereof.
- Xa is 0.5 to 5.5, preferably 1.0 to 5.5, more preferably 2.0 to 5.0.
- An oral composition is provided in which the amino acid or a derivative thereof or a salt thereof comprises an amino acid selected from DL-alanine, L-serine, glycine, L-arginine, L-glutamic acid, L-valine and L-glutamine.
- the amount of the high sweetness sweetener may be from about 20 ppm to about 600 ppm, from about 30 ppm to about 550 ppm, or from about 55 ppm to about 490 ppm.
- It contains (a) a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, and (b) an amino acid below the taste recognition threshold or a derivative thereof or a salt thereof.
- the components (a) and (b) exhibit sweetness with a sweetness intensity of Xb, and 0.1 ⁇ Xa ⁇ Xb.
- the good-tasting, high-sweetness sweetener is selected from a high-sweetness sweetener selected from rebaugioside D, rebaugioside M, mogroside V, Luo Han Guo extract and combinations thereof, preferably rebaugioside D, rebaugioside M and combinations thereof.
- Xa is 0.5 to 10.0, preferably 1.5 to 9.0, more preferably 2.0 to 8.0.
- An oral composition is provided in which the amino acid or a derivative thereof or a salt thereof comprises an amino acid selected from DL-alanine, L-serine, glycine, L-arginine, L-glutamic acid, L-valine and L-glutamine.
- the amount of the high sweetness sweetener may be from about 20 ppm to about 600 ppm, from about 30 ppm to about 550 ppm, or from about 55 ppm to about 490 ppm.
- the good-tasting, high-sweetness sweetener is selected from a high-sweetness sweetener selected from rebaugioside D, rebaugioside M, mogroside V, Luo Han Guo extract and combinations thereof, preferably rebaugioside D, rebaugioside M and combinations thereof.
- Xa is 0.5 to 5.5, preferably 1.0 to 5.5, more preferably 2.0 to 5.0.
- Amino acids or derivatives thereof or salts thereof contain amino acids selected from DL-alanine, L-serine, glycine, L-arginine, L-glutamic acid, L-valine and L-glutamine.
- Low sweetness sweeteners include sweeteners selected from glucose, sucrose, fructose, maltose, oligosaccharides, high fructose corn syrup, lactose, psicose, allose, tagatose, xylose, ribose and combinations thereof.
- compositions are provided in which the Xc is 0.05-6.0, preferably 0.05-5.0, more preferably 0.1-4.0.
- the amount of the high sweetness sweetener may be from about 20 ppm to about 600 ppm, from about 30 ppm to about 550 ppm, or from about 55 ppm to about 490 ppm.
- It contains (a) a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, and (b) an amino acid below the taste recognition threshold or a derivative thereof or a salt thereof.
- the components (a) and (b) exhibit sweetness with a sweetness intensity of Xb, and 0.1 ⁇ Xa ⁇ Xb.
- the good-tasting, high-sweetness sweetener is selected from a high-sweetness sweetener selected from rebaugioside D, rebaugioside M, mogroside V, Luo Han Guo extract and combinations thereof, preferably rebaugioside D, rebaugioside M and combinations thereof.
- Xa is 0.5 to 5.5, preferably 1.0 to 5.5, more preferably 2.0 to 5.0.
- An oral composition is provided in which an amino acid or a derivative thereof or a salt thereof comprises an amino acid or an amino acid salt selected from L-leucine, L-threonine, L-proline, L-asparagine and L-lysine hydrochloride.
- the amount of the high sweetness sweetener may be from about 20 ppm to about 600 ppm, from about 30 ppm to about 550 ppm, or from about 150 ppm to about 400 ppm.
- It contains (a) a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, and (b) an amino acid below the taste recognition threshold or a derivative thereof or a salt thereof.
- the components (a) and (b) exhibit sweetness with a sweetness intensity of Xb, and 0.1 ⁇ Xa ⁇ Xb.
- the good-tasting, high-sweetness sweetener is selected from a high-sweetness sweetener selected from rebaugioside D, rebaugioside M, mogroside V, Luo Han Guo extract and combinations thereof, preferably rebaugioside D, rebaugioside M and combinations thereof.
- Xa is 0.5 to 10.0, preferably 1.5 to 9.0, more preferably 2.0 to 8.0.
- An oral composition is provided in which an amino acid or a derivative thereof or a salt thereof comprises an amino acid or an amino acid salt selected from L-leucine, L-threonine, L-proline, L-asparagine and L-lysine hydrochloride.
- the amount of the high sweetness sweetener may be from about 20 ppm to about 600 ppm, from about 30 ppm to about 550 ppm, or from about 150 ppm to about 400 ppm.
- the good-tasting, high-sweetness sweetener is selected from a high-sweetness sweetener selected from rebaugioside D, rebaugioside M, mogroside V, Luo Han Guo extract and combinations thereof, preferably rebaugioside D, rebaugioside M and combinations thereof.
- Xa is 0.5 to 5.5, preferably 1.0 to 5.5, more preferably 2.0 to 5.0.
- Amino acids or derivatives thereof or salts thereof contain amino acids or amino acid salts selected from L-leucine, L-threonine, L-proline, L-asparagine and L-lysine hydrochloride.
- Low sweetness sweeteners include sweeteners selected from glucose, sucrose, fructose, maltose, oligosaccharides, high fructose corn syrup, lactose, psicose, allose, tagatose, xylose, ribose and combinations thereof.
- compositions are provided in which the Xc is 0.05-6.0, preferably 0.05-5.0, more preferably 0.1-4.0.
- the amount of the high sweetness sweetener may be from about 20 ppm to about 600 ppm, from about 30 ppm to about 550 ppm, or from about 150 ppm to about 400 ppm.
- the present invention provides the following method for producing an oral composition with increased sweetness (hereinafter, referred to as “the method for producing the present invention”).
- the method for producing the present invention (A) Addition of a good-quality, high-sweetness sweetener in an amount equivalent to the sweetness intensity Xa, (B) The method for producing an oral composition of the present invention, which comprises adding an amino acid below the taste recognition threshold or a derivative thereof or a salt thereof.
- the oral composition produced by the method of the present invention is the oral composition of the present invention described in the above item "1. Oral composition with increased sweetness exhibited by a good-tasting, high-sweetness sweetener".
- the "raw material” in the method of the present invention may be each material or a mixture thereof necessary for producing an oral composition, and further contains additional components such as preservatives, flavors, carriers, and fruit juices. May be good. Further, the "raw material” may be composed of a plurality of materials.
- any of the following (a) and (b) may be performed first.
- two steps are carried out at the same time. You may.
- step (a) an amount of good quality high sweetness sweetener equivalent to sweetness intensity Xa is added to the raw material, but it is not necessary to add an amount of natural sugar equivalent to sweetness intensity Xa at a time, and the number It may be added in divided doses.
- step (b) When adding amino acids below the taste recognition threshold in step (b), it is not necessary to add amino acids below the taste recognition threshold at one time, and the amino acids may be added in several times.
- the amino acid or its derivative or its salt added to the raw material in the step (b) is the amino acid or its derivative or its salt described in the above item "1. Oral composition with increased sweetness exhibited by a good-tasting, high-sweetness sweetener". You can choose from salt.
- addition not only means an operation of actually adding either of the components (a) and (b) to the raw material, but is finally produced through the manufacturing process of the oral composition of the present invention. It also means an operation of adjusting the amounts of the components (a) and (b) in the oral composition to predetermined amounts, respectively.
- the first raw material contains fruit juice, grains, beans and extracts thereof, so that the raw material contains one or more of the components (a) and (b) in advance and is mixed with the first raw material.
- the oral composition of the present invention is (a) high quality in an amount equivalent to the sweetness intensity Xa.
- Sweetness Steps (a) and (b) are considered to have been performed as long as they contain a sweetener, (b) an amino acid below the taste recognition threshold or a derivative thereof or a salt thereof.
- the production method of one aspect of the present invention further includes (c) adding an amount of a low-sweetness sweetener corresponding to the sweetness intensity Xc.
- the oral composition of Aspect A can be produced by the production method of Aspect A.
- the steps (a) to (c) may be performed separately, or two or more steps may be performed at the same time. For example, (a) and (b), (a) and (c), (b) and (c) or (a) and (b) and (c) may be performed at the same time.
- oral composition "sweetness intensity Xa”, “good taste high sweetness sweetener”, “sweetness intensity Xb”, “amino acid or derivative thereof or salt thereof”, “optional ingredient”, “Low sweetness sweetener”, “sweetness intensity Xc”, “sweetness intensity Xd”, “other ingredients” and energy are the same as the definitions described in the item of the above oral composition, and the numerical values are the same as the above oral composition.
- the numbers mentioned in the item of things apply as they are.
- the present invention provides, as a third aspect, a method for enhancing the sweetness of the following oral composition (hereinafter, referred to as "the method for enhancing the present invention").
- a method for enhancing the sweetness of the oral composition which comprises adding an amino acid below the taste recognition threshold to the oral composition containing a good-quality, high-sweetness sweetener.
- an oral composition that enhances the sweetness of the oral composition and exhibits a sweetness that exceeds the sweetness intensity when the component (a) is simply added to the oral composition.
- amino acids are added simultaneously or separately to an oral composition containing a predetermined amount of a good-quality, high-sweetness sweetener, and after the addition, the oral composition contains amino acids below the taste recognition threshold. By doing so, the sweetness of the oral composition is brought about a sweetness that exceeds the sweetness intensity when only a good-quality, high-sweetness sweetener is added.
- the amount of amino acid added in the oral composition is 100 mM or less, 90 mM or less, 80 mM or less, 70 mM or less, 60 mM or less, 50 mM or less, 40 mM or less, 30 mM or less, 20 mM or less, 15 mM.
- 14 mM or less 13 mM or less, 12 mM or less, 11 mM or less, 10 mM or less, 9.5 mM or less, 9.0 mM or less, 8.5 mM or less, 8.0 mM or less, 7.5 mM or less, 7.0 mM or less, 6.5 mM or less, 6.0 mM or less, 5.5 mM or less, 5.0 mM or less, 4.5 mM or less, 4.0 mM or less, 3.5 mM or less, 3.0 mM or less, 2.5 mM or less, 2.0 mM or less, 1.5 mM or less, 1.0 mM or less, 0.5 mM or less, 0.5 to 100 mM, 1.0 to 100 mM , 1.5-100mM, 2.0-100mM, 2.5-100mM, 3.0-100mM, 3.5-100mM, 4.0-100mM, 4.5-100mM, 5.0-100mM,
- oral composition "sweetness intensity Xa”, “good quality high sweetness sweetener”, “sweetness intensity Xb”, “amino acid or derivative thereof or salt thereof”, “optional ingredient” , "Sweetness Sweetness”, “Sweetness Intensity Xc”, “Sweetness Intensity Xd”, "Other Ingredients” and energy are the same as the definitions given in the above Oral Composition section, and the values are the same as above. The values mentioned in the section on effervescent beverages apply as they are.
- the present invention provides a concentrate for providing the following oral composition (hereinafter, referred to as "enhancement method of the present invention”).
- the concentrate of the present invention is used to provide an oral composition diluted at an arbitrary ratio.
- the "oral composition” is the same as that described for "1.
- Oral composition with increased sweetness exhibited by a high-quality, high-sweetness sweetener" can be used in beverages as a syrup or undiluted solution. At that time, it can be diluted 2-fold, 3-fold, 4-fold, 5-fold, 6-fold, 7-fold, 8-fold, 9-fold or 10-fold before use.
- the concentrate of the present invention since the concentrate of the present invention is concentrated, it is preferable in terms of storage stability and transportability.
- the concentrate of the present invention may be solid or liquid.
- the concentrate of the present invention is a 2- to 10-fold concentrate of the oral composition of the present invention, preferably a 3- to 9-fold concentrate, more preferably a 4- to 8-fold concentrate, and even more preferably. It is a 5 to 7 times concentrated concentrate.
- the concentrate according to one aspect of the present invention is a 5-fold concentrate of the effervescent beverage of the present invention.
- A Good-quality, high-sweetness sweetener in an amount equivalent to sweetness intensity Xaa
- b Contains amino acids or derivatives thereof or salts thereof, which are less than 5 times the taste recognition threshold.
- the components (a) and (b) exhibit sweetness with a sweetness intensity of Xba, and 0.5 ⁇ Xaa ⁇ Xba ⁇ 100, preferably 1.0 ⁇ Xaa ⁇ Xba ⁇ 50, and more preferably 2.0 ⁇ Xaa ⁇ Xba ⁇ 25.
- the concentrate according to another aspect of the present invention is a 10-fold concentrate of the effervescent beverage of the present invention.
- A Good-quality, high-sweetness sweetener in an amount equivalent to sweetness intensity Xab
- b Contains amino acids or derivatives thereof or salts thereof, which are less than 10 times the taste recognition threshold.
- the components (a) and (b) exhibit sweetness with a sweetness intensity of Xbb, and 1.0 ⁇ Xab ⁇ Xbb ⁇ 200, preferably 2.0 ⁇ Xab ⁇ Xbb ⁇ 100, and more preferably 4.0 ⁇ Xab ⁇ Xbb ⁇ 50.
- the word “about” exists in the range of ⁇ 25%, ⁇ 10%, ⁇ 5%, ⁇ 3%, ⁇ 2% or ⁇ 1% of the numerical value following "about”.
- “about 10” means the range of 7.5 to 12.5.
- “mM” means molar concentration and means 1 ⁇ 10 -3 mol / L.
- Example 1 Evaluation of sweetness increasing effect by adding amino acids
- sensory evaluation was performed on samples using various amino acids shown in Table 2.
- pure natural sugar ⁇ sucrose (manufactured by Pacific Sugar Manufacturing Co., Ltd.), glucose (manufactured by Showa Sangyo Co., Ltd.) ⁇ , rebaugioside D (RebD) (purity 95% or more) and various amino acids are added in the ratio shown in Table 2 below.
- Beverage samples were prepared by dissolving in water.
- Amino acids include glycine (purity 98.5% or higher), DL-alanine (purity 98% or higher), L-serine (purity 98.5% or higher), L-phenylalanine (purity 99% or higher), L-tryptophan (purity 99% or higher). ), L-Methionine (purity 99% or higher), L-proline (purity 98% or higher), L-glutamine (purity 98% or higher), L-arginine (purity 98.5% or higher), L-glutamic acid (purity 99% or higher) ) And L-aspartic acid (purity 99% or higher) were used. The amount of amino acid added is described in the literature (Susan S.
- Example 2 Measurement of taste recognition thresholds of a plurality of amino acids For alanine, serine, glycine, arginine, glutamic acid, valine and glutamine, aqueous solutions having the concentrations shown in Table 3 below were prepared. Each sample contained only water and amino acids. These samples were evaluated according to the following criteria by panelists who were trained in sensuality (5 to 6 people). Evaluation criteria ⁇ : No taste other than water ⁇ : Different from water but the taste cannot be specified ⁇ : Feel the taste ⁇ : Feel the very strong taste
- Example 3 Measurement of sweetness intensity of beverage samples Beverage samples 1-1 and 1-2 shown in the table below are compared with a sucrose solution of Brix 8 (8 w / v%), graded on a VAS scale, and each beverage is scored. The sweetness intensity of the sample was calculated. Those who were trained in sensuality (5 people) acted as panelists and evaluated. The results are shown in Table 5.
- Example 4 Measurement of taste cognitive threshold The taste cognitive threshold was actually measured for a plurality of amino acids or salts thereof by the same method as in Example 2. Aqueous solutions having the concentrations shown in Table 6 below were prepared for leucine, threonine, proline, asparagine and lysine hydrochloride. Each sample contained only water and amino acids or salts thereof. These samples were evaluated according to the following criteria by panelists who were trained in sensuality (6 to 7 people). Evaluation criteria ⁇ : No taste other than water ⁇ : Different from water but the taste cannot be specified ⁇ : Feel the taste ⁇ : Feel the very strong taste
- Example 5 Confirmation of sweetness increasing effect by amino acid or salt thereof Confirmation of sweetness increasing effect by a plurality of concentration levels of a plurality of amino acids or salts thereof based on the taste recognition threshold obtained in Example 2 or Example 4.
- Amino acids include L-leucine (purity 98.0% or higher), L-threonine (purity 98.0% or higher), L-proline (purity 98.0% or higher), L-asparagine (purity 99.0% or higher) and L-lysine hydrochloride (purity 99.0% or higher). Purity 98.0% or higher) was used. The solution to which no amino acid was added was used as a control (Cont.) Solution. The energy (kcal / 100 ml) in Table 8 was calculated with 0 (kcal / 100 ml) derived from RebD.
- Example 6 Confirmation of sweetness increasing effect at a plurality of concentration levels of an amino acid or a salt thereof The sweetness increasing effect was confirmed at a plurality of concentration levels based on the taste recognition threshold obtained in Example 2 or Example 4.
- Natural sugar ⁇ sucrose (manufactured by Pacific Sugar Manufacturing Co., Ltd.), glucose (manufactured by Showa Sangyo Co., Ltd.) ⁇ , rebaugioside D (RebD) (purity 95% or more) and various amino acids or their respective ratios shown in Tables 9 to 11 below. Beverage samples were prepared by dissolving the salt in pure water.
- DL-alanine purity 98% or more
- L-proline purity 98.0% or more
- L-lysine hydrochloride purity 98.0% or more
- the solution to which no amino acid was added was used as a control (Cont.) Solution.
- the energy (kcal / 100 ml) in Tables 9 to 11 was calculated with 0 (kcal / 100 ml) derived from RebD.
- Example 7 Evaluation of sweetness increasing effect when various high-sweetness sweeteners are blended As shown in Table 12 below, “sucrose, glucose”, “RebM, MogV or Luo Han Guo extract” and amino acids or salts thereof (DL-alanine). (Purity 98% or higher) or L-lysine hydrochloride (purity 98.0% or higher)) was dissolved in pure water to prepare a sample solution. The purity of RebM used was 98%, the purity of MogV was 97.7%, and the Luo Han Guo extract was a water extract of Luo Han Guo fruit containing 40% by weight mogroside V.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Seasonings (AREA)
- Cosmetics (AREA)
Abstract
Description
しかしながら、低カロリー食品にするためには糖濃度を低く抑える必要があり、この点が低カロリーかつ良好な味覚を呈する食品を提供する際の障害となっている。
[1]
(a)甘味強度Xa相当の量の良味質高甘味度甘味料、および
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbである、経口組成物。
[2]
前記アミノ酸が、塩基性アミノ酸および側鎖にアルキル基、OH基、硫黄含有基またはイミノ基を有する中性アミノ酸ならびにその組合せから選択されるアミノ酸を含む、[1]に記載の経口組成物。
[3]
前記アミノ酸が、分子量70~260 のアミノ酸から選択される1種以上である、[1]または[2]に記載の経口組成物。
[4]
前記アミノ酸が、アラニン、セリン、プロリン、メチオニンおよびアルギニンならびにその組合せから選択されるアミノ酸を含む、[1]~[3]のいずれかに記載の経口組成物。
[5]
低甘味度甘味料をさらに含む、[1]~[4]のいずれかに記載の経口組成物。
[6]
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せを含む、[1]~[5]のいずれかに記載の経口組成物。[6-1]
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料を含む、[1]~[5]のいずれかに記載の経口組成物。
[7]
前記低甘味度甘味料が、ヘキソース、ペントース、テトロース、末端糖がアルドースまたはケトースである多糖、糖アルコールおよびその組合せから選択される甘味料を含む、[5]または[6]に記載の経口組成物。
[7-1]
前記低甘味度甘味料が、ヘキソース、ペントース、テトロース、末端糖がアルドースまたはケトースである多糖、糖アルコールおよびその組合せから選択される甘味料を含む、[5]、[6]または[6-1]に記載の経口組成物。
[8]
前記低甘味度甘味料が、グルコース、スクロース、フルクトース、マルトース、オリゴ糖、異性化糖、乳糖、プシコース、アロース、タガトース、キシロース、リボースおよびその組合せから選択される甘味料を含む、[5]または[6]に記載の経口組成物。
[8-1]
前記低甘味度甘味料が、グルコース、スクロース、フルクトース、マルトース、オリゴ糖、異性化糖、乳糖、プシコース、アロース、タガトース、キシロース、リボースおよびその組合せから選択される甘味料を含む、[5]、[6]または[6-1]に記載の経口組成物。
[9]
食品である、[1]~[8]のいずれかに記載の経口組成物。
[9-1]
食品である、[1]~[8-1]のいずれかに記載の経口組成物。
[10]
前記食品が飲料である、[9]に記載の経口組成物。
[10-1]
前記食品が飲料である、[9-1]に記載の経口組成物。
[11]
(a)甘味強度Xa相当の量の良味質高甘味度甘味料を添加すること、および
(b)味覚認知閾値未満のアミノ酸もしくはその塩を添加すること
を含む、[1]~[9]のいずれかに記載の経口組成物の製造方法。
[11-1]
(a)甘味強度Xa相当の量の良味質高甘味度甘味料を添加すること、および
(b)味覚認知閾値未満のアミノ酸もしくはその塩を添加すること
を含む、[1]~[9-1]のいずれかに記載の経口組成物の製造方法。
[12]
良味質高甘味度甘味料を含む経口組成物に、味覚認知閾値未満のアミノ酸を添加することを含む、前記経口組成物の甘味度を増強する方法。
なお、本明細書において引用した全ての文献、および公開公報、特許公報その他の特許文献は、参照として本明細書に組み込むものとする。また、本明細書は、2019年12月27日および2020年6月5日に出願された本願優先権主張の基礎となる日本国特許出願(特願2019-238755号および特願2020-098803号)の明細書及び図面に記載の内容を包含する。
本発明は、第1の態様として、以下の経口組成物(以下、「本発明の経口組成物」という)を提供する。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbである、経口組成物。
本明細書において、「経口組成物」は固体、流動体、および液体、ならびにそれらの混合物であって、経口摂食可能なものの総称である。本発明の経口組成物には、食品が包含され、食品には飲料が包含される。本発明の経口組成物の例としては、栄養補助食品、健康食品、機能性食品、幼児用食品、乳児用調製乳、未熟児用調製乳、老人用食品等が挙げられる。
乳製品の例としてはバター、チーズ、ヨーグルト、ギイ等が挙げられる。
菓子類の例としては、飴、ジャム、チューインガム、アイスクリーム、スナック菓子、クッキー、ビスケット、ケーキ、ウェハース、菓子パン、チョコレート、和菓子等が挙げられるがこれらに限定されるものではない。
さらに、本発明の経口組成物は容器詰め殺菌されたものであってもよい。
本明細書において、「甘味強度」は物質の呈する甘味の強さを意味する。例えば、単位濃度Brix1当たりのショ糖が呈する甘味強度を甘味度1と定めた場合、ブドウ糖の甘味度は0.6~0.7(中心値0.65)となる。この甘味度にブドウ糖の濃度Brix値を乗じて得られる数値がブドウ糖の甘味強度となる。したがって、ブドウ糖の濃度がBrix1.5の場合、ブドウ糖の甘味強度は0.65×1.5=0.975となる。
さらには、上記測定において本発明の経口組成物よりも甘味が少ない基準経口組成物のうち、本発明の経口組成物と最も甘味の近い基準経口組成物を選択し、当該選択された基準経口組成物にショ糖を追加することによって本発明の経口組成物と同じ甘味を呈するように調整し、その際に、調整後の基準経口組成物に含まれるショ糖含有量から、本発明の経口組成物について甘味強度を測定することもできる。
本明細書において、「良味質高甘味度甘味料」(本明細書中、「甘味料(a)」または「成分(a)」と略すことがある)は、レバウジオシドA(RebA)と比べ、(1)収斂味が少ない、(2)金属味が少ない、(3)甘味の後引きが少ない、(4)苦味が少ない、から選択される1以上の味質特性を有する、高甘味度甘味物質を意味する。ある甘味物質が上記味質特性を有するかどうかは既知であるか、官能評価などに基づき決定することができる。本発明の一態様において、良味質高甘味度甘味料は植物などの中に天然に存在するものでも、人工的に生成されたもの(例えば、バイオコンバージョンや化学合成など)であってもよいが、好ましくは天然に存在する甘味料である。本明細書において「天然に存在する」とは、本発明の経口組成物に含まれる高甘味度甘味物質が天然物であることを意味するのではなく、同じ物質が天然に存在していれば、本発明の経口組成物に含まれる高甘味度甘味物質は人工的に(例えばバイオコンバージョンなどにより)生成されたもの(非天然物)であってもよい。
本発明に用いられるアミノ酸またはアミノ酸塩としては、アミノ基とカルボキシル基の両方の官能基を有する有機化合物またはその塩であって、甘み増大効果が得られるものであれば特に限定されない。また、アミノ基の水素が分子内の側鎖部分と置換して環状構造を形成しているプロリンやヒドロキシプロリンも本明細書においてアミノ酸に包含する。本発明に用いられるアミノ酸誘導体としては、タウリンのようにカルボキシル基を有さない誘導体も包含される。
(甘味料)
本発明の経口組成物は、成分(a)の良味質高甘味度甘味料以外にも甘味料を含み得る。本明細書において「甘味料」は甘味応答を引き起こす任意の物質または物質群を意味する。甘味料は、構造上の特徴から糖質系甘味料と非糖質系甘味料に、また、甘味度に基づき、低甘味度甘味料と高甘味度甘味料に分けることができる。また、エネルギー(カロリー)に基づき、甘味物質をカロリー性甘味料と非カロリー性甘味料に分けることもできる。なお、下記の甘味料のうち、良味質高甘味度甘味料にも分類されるものは、成分(a)に含めるものとする。
カンゾウ抽出物とは、ウラルカンゾウ、チョウカカンゾウまたはヨウカンゾウの根または根茎から得られた、グリチルリチン酸を主成分とするものをいう。カンゾウ抽出物の例としてはカンゾウエキス、グリチルリチン、リコリス抽出物が挙げられる。
ショ糖誘導体は、例えば、ショ糖のOH基またはH基を別の置換基で置換して得られるものを含み、その例としては、ショ糖のハロゲン誘導体(スクラロース)、オキサチアジノンジオキシド誘導体、糖アルコール、アルドン酸、ウロン酸等が挙げられる。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩、および
(c)甘味強度Xc相当の量の低甘味度甘味料
を含み、
前記成分(a)~(c)により甘味強度Xdの甘味を呈し、0.1<Xa+Xc<Xdである、経口組成物。本発明の一態様における経口組成物は、(a)甘味強度Xa相当の量の良味質高甘味度甘味料と(c)甘味強度Xc相当の量の低甘味度甘味料以外の成分を甘味料として含まない。
低甘味度甘味料の甘味強度Xc相当の量とは、本発明の経口組成物と同等体積の20℃の水に低甘味度甘味料を溶かした条件で甘味強度Xcの甘味を呈する量(濃度)をいう。
本発明の経口組成物は、本発明の効果を損なわない限りにおいて、酸化防止剤(エリソルビン酸ナトリウムなど)、乳化剤(ショ糖脂肪酸エステル、ソルビタン脂肪酸エステル、ポリグリセリン脂肪酸エステルなど)、酸味料、香料等を適宜配合することができる。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料、および
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbであり、
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料、好ましくは、レバウジオシドD、レバウジオシドMおよびその組み合わせから選択される高甘味度甘味料、を含み、
Xaが、0.5~5.5、好ましくは1.0~5.5、より好ましくは2.0~5.0であり、
アミノ酸またはその誘導体もしくはその塩が、DL-アラニン、L-セリン、グリシン、L-アルギニン、L-グルタミン酸、L-バリンおよびL-グルタミンから選択されるアミノ酸を含む、経口組成物が提供される。本態様において、高甘味度甘味料の量は、約20ppm~約600ppm、約30ppm~約550ppm、または約55ppm~約490ppmであってもよい。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料、および
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbであり、
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料、好ましくは、レバウジオシドD、レバウジオシドMおよびその組み合わせから選択される高甘味度甘味料、を含み、
Xaが、0.5~10.0、好ましくは1.5~9.0、より好ましくは2.0~8.0であり、
アミノ酸またはその誘導体もしくはその塩が、DL-アラニン、L-セリン、グリシン、L-アルギニン、L-グルタミン酸、L-バリンおよびL-グルタミンから選択されるアミノ酸を含む、経口組成物が提供される。本態様において、高甘味度甘味料の量は、約20ppm~約600ppm、約30ppm~約550ppm、または約55ppm~約490ppmであってもよい。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩、および
(c)甘味強度Xc相当の量の低甘味度甘味料
を含み、
前記成分(a)~(c)により甘味強度Xdの甘味を呈し、0.1<Xa+Xc<Xdであり、
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料、好ましくは、レバウジオシドD、レバウジオシドMおよびその組み合わせから選択される高甘味度甘味料、を含み、
Xaが、0.5~5.5、好ましくは1.0~5.5、より好ましくは2.0~5.0であり、
アミノ酸またはその誘導体もしくはその塩が、DL-アラニン、L-セリン、グリシン、L-アルギニン、L-グルタミン酸、L-バリンおよびL-グルタミンから選択されるアミノ酸を含み、
低甘味度甘味料が、グルコース、スクロース、フルクトース、マルトース、オリゴ糖、異性化糖、乳糖、プシコース、アロース、タガトース、キシロース、リボースおよびその組合せから選択される甘味料を含み、
Xcが、0.05~6.0、好ましくは0.05~5.0、より好ましくは0.1~4.0である、経口組成物が提供される。本態様において、高甘味度甘味料の量は、約20ppm~約600ppm、約30ppm~約550ppm、または約55ppm~約490ppmであってもよい。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料、および
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbであり、
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料、好ましくは、レバウジオシドD、レバウジオシドMおよびその組み合わせから選択される高甘味度甘味料、を含み、
Xaが、0.5~5.5、好ましくは1.0~5.5、より好ましくは2.0~5.0であり、
アミノ酸またはその誘導体もしくはその塩が、L-ロイシン、L-スレオニン、L-プロリン、L-アスパラギンおよびL-リジン塩酸塩から選択されるアミノ酸またはアミノ酸塩を含む、経口組成物が提供される。本態様において、高甘味度甘味料の量は、約20ppm~約600ppm、約30ppm~約550ppm、または約150ppm~約400ppmであってもよい。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料、および
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbであり、
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料、好ましくは、レバウジオシドD、レバウジオシドMおよびその組み合わせから選択される高甘味度甘味料、を含み、
Xaが、0.5~10.0、好ましくは1.5~9.0、より好ましくは2.0~8.0であり、
アミノ酸またはその誘導体もしくはその塩が、L-ロイシン、L-スレオニン、L-プロリン、L-アスパラギンおよびL-リジン塩酸塩から選択されるアミノ酸またはアミノ酸塩を含む、経口組成物が提供される。本態様において、高甘味度甘味料の量は、約20ppm~約600ppm、約30ppm~約550ppm、または約150ppm~約400ppmであってもよい。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩、および
(c)甘味強度Xc相当の量の低甘味度甘味料
を含み、
前記成分(a)~(c)により甘味強度Xdの甘味を呈し、0.1<Xa+Xc<Xdであり、
前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料、好ましくは、レバウジオシドD、レバウジオシドMおよびその組み合わせから選択される高甘味度甘味料、を含み、
Xaが、0.5~5.5、好ましくは1.0~5.5、より好ましくは2.0~5.0であり、
アミノ酸またはその誘導体もしくはその塩が、L-ロイシン、L-スレオニン、L-プロリン、L-アスパラギンおよびL-リジン塩酸塩から選択されるアミノ酸またはアミノ酸塩を含み、
低甘味度甘味料が、グルコース、スクロース、フルクトース、マルトース、オリゴ糖、異性化糖、乳糖、プシコース、アロース、タガトース、キシロース、リボースおよびその組合せから選択される甘味料を含み、
Xcが、0.05~6.0、好ましくは0.05~5.0、より好ましくは0.1~4.0である、経口組成物が提供される。本態様において、高甘味度甘味料の量は、約20ppm~約600ppm、約30ppm~約550ppm、または約150ppm~約400ppmであってもよい。
本発明は、第2の態様として、以下の甘味が増大された経口組成物の製造方法(以下、「本発明の製造方法」という)を提供する。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料を添加すること、
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩を添加すること
を含む、本発明の経口組成物の製造方法。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料を添加すること
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩を添加すること
また、2つの工程が同時に行われてもよい。
例えば、第1の原材料に果汁、穀類、豆類やその抽出物が含まれ、そのために原材料に予め成分(a)および(b)のいずれか1つ以上が含まれ、第1の原材料と混合するための第2の原材料においても成分(a)および(b)が含まれ、第1および第2の原材料を混合することにより本発明の経口組成物が製造できた場合、成分(a)および(b)を個別に原材料に追加する操作は存在していないが、本発明の方法では、最終的に製造される本発明の経口組成物が(a)甘味強度Xa相当の量の良味質高甘味度甘味料、(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩を含む限り、工程(a)および(b)は行われたものとみなす。
本発明は、第3の態様として、以下の経口組成物の甘味度を増強する方法(以下、「本発明の増強方法」という)を提供する。
良味質高甘味度甘味料を含む経口組成物に、味覚認知閾値未満のアミノ酸を添加することを含む、前記経口組成物の甘味度を増強する方法。
本発明は、第4の態様として、以下の経口組成物を提供するための濃縮物(以下、「本発明の増強方法」という)を提供する。
(a)甘味強度Xa相当の量の良味質高甘味度甘味料
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbである経口組成物。
(a)甘味強度Xaa相当の量の良味質高甘味度甘味料
(b)味覚認知閾値の5倍未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbaの甘味を呈し、0.5<Xaa<Xba<100、好ましく1.0<Xaa<Xba<50、より好ましくは2.0<Xaa<Xba<25である。
(a)甘味強度Xab相当の量の良味質高甘味度甘味料
(b)味覚認知閾値の10倍未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbbの甘味を呈し、1.0<Xab<Xbb<200、好ましく2.0<Xab<Xbb<100、より好ましくは4.0<Xab<Xbb<50である。
アミノ酸を飲料に加えた際の甘み増大効果を評価するために、表2に示す種々のアミノ酸を用いた試料について官能評価を行った。
まず、下記の表2に示した比率で天然糖{スクロース(太平洋製糖株式会社製)、グルコース(昭和産業株式会社製)}、レバウジオシドD(RebD)(純度95%以上)および種々のアミノ酸を純水に溶解して、飲料サンプルを調製した。アミノ酸としては、グリシン(純度98.5%以上)、DL-アラニン(純度98%以上)、L-セリン(純度98.5%以上)、L-フェニルアラニン(純度99%以上)、L-トリプトファン(純度99%以上)、L-メチオニン(純度99%以上)、L-プロリン(純度98%以上)、L-グルタミン(純度98%以上)、L-アルギニン(純度98.5%以上)、L-グルタミン酸(純度99%以上)およびL-アスパラギン酸(純度99%以上)を使用した。アミノ酸添加量は、文献(Susan S. Schiffmanら、“Comparison of Taste Qualities and Thresholds of D- and L-Amino Acids”, Physiology & Behavior, Vol. 27, pp. 51-59 (1981))に記載の検知閾値を考慮して決定した。また、アミノ酸を添加していない溶液をコントロール(Cont.)溶液とした。なお、表2におけるBrixは天然糖の濃度から、エネルギー(kcal/100ml)はRebD由来を0(kcal/100ml)として、それぞれ算出した。通常、飲料中のアミノ酸含有量は、アミノ酸添加量からの計算か高速液体クロマトグラフィー(HPLC)などの公知の方法で確認することができる。
アラニン、セリン、グリシン、アルギニン、グルタミン酸、バリンおよびグルタミンについて、下記表3の濃度の水溶液を調製した。各サンプルは水とアミノ酸のみを含んでいた。これらのサンプルを、官能に関して訓練を受けた者(5~6名)がパネラーとなって下記の基準で評価した。
評価基準
◎:水以外の味を感じない
○:水とは異なるが味を特定できない
△:味を感じる
×:非常に強い味を感じる
下表に記載の飲料サンプル1-1および1-2と、Brix8のスクロース溶液(8w/v%)を比較して、VASスケールで評点し、各飲料サンプルの甘味強度を算出した。官能に関して訓練を受けた者(5名)がパネラーとなって評価を実施した。結果を表5に示す。
複数のアミノ酸またはその塩について、実施例2と同じ方法で、味覚認知閾値の実測を行った。ロイシン、スレオニン、プロリン、アスパラギンおよびリジン塩酸塩について、下記表6の濃度の水溶液を調製した。各サンプルは水とアミノ酸またはその塩のみを含んでいた。これらのサンプルを、官能に関して訓練を受けた者(6~7名)がパネラーとなって下記の基準で評価した。
評価基準
◎:水以外の味を感じない
○:水とは異なるが味を特定できない
△:味を感じる
×:非常に強い味を感じる
複数のアミノ酸またはその塩について、実施例2または実施例4で得た味覚認知閾値を基準として、複数の濃度水準で甘み増大効果を確認した。下記の表8に示した比率で天然糖{スクロース(太平洋製糖株式会社製)、グルコース(昭和産業株式会社製)}、レバウジオシドD(RebD)(純度95%以上)および種々のアミノ酸またはその塩を純水に溶解して、飲料サンプルを調製した。アミノ酸としては、L-ロイシン(純度98.0%以上)、L-スレオニン(純度98.0%以上)、L-プロリン(純度98.0%以上)、L-アスパラギン(純度99.0%以上)およびL-リジン塩酸塩(純度98.0%以上)を使用した。また、アミノ酸を添加していない溶液をコントロール(Cont.)溶液とした。なお、表8におけるエネルギー(kcal/100ml)はRebD由来を0(kcal/100ml)として算出した。
実施例2または実施例4で得た味覚認知閾値を基準として、複数の濃度水準で甘み増大効果を確認した。下記の表9~11に示した比率で天然糖{スクロース(太平洋製糖株式会社製)、グルコース(昭和産業株式会社製)}、レバウジオシドD(RebD)(純度95%以上)および種々のアミノ酸またはその塩を純水に溶解して、飲料サンプルを調製した。アミノ酸としては、DL-アラニン(純度98%以上)、L-プロリン(純度98.0%以上)およびL-リジン塩酸塩(純度98.0%以上)を使用した。また、アミノ酸を添加していない溶液をコントロール(Cont.)溶液とした。なお、表9~11におけるエネルギー(kcal/100ml)はRebD由来を0(kcal/100ml)として算出した。
下記表12のように「スクロース、グルコース」、「RebM、MogVまたは羅漢果抽出物」およびアミノ酸またはその塩(DL-アラニン(純度98%以上)またはL-リジン塩酸塩(純度98.0%以上))を純水に溶解し、サンプル溶液を調製した。使用したRebMの純度は98%であり、MogVの純度は97.7%であり、羅漢果抽出物は40重量%モグロシドVを含有する、羅漢果果実の水抽出物であった。また、それぞれの溶液において、アミノ酸またはその塩(DL-アラニンまたはL-リジン塩酸塩)を添加していない溶液をコントロール溶液とした。得られたサンプルにおいて、実施例6と同様に官能により甘味増大効果を評価した。結果を表12に示す。
Claims (12)
- (a)甘味強度Xa相当の量の良味質高甘味度甘味料、および
(b)味覚認知閾値未満のアミノ酸またはその誘導体もしくはその塩
を含み、
前記成分(a)および(b)により甘味強度Xbの甘味を呈し、0.1<Xa<Xbである、経口組成物。 - 前記アミノ酸が、塩基性アミノ酸および側鎖にアルキル基、OH基、硫黄含有基またはイミノ基を有する中性アミノ酸ならびにその組合せから選択されるアミノ酸を含む、請求項1に記載の経口組成物。
- 前記アミノ酸が、分子量70~260のアミノ酸から選択される1種以上である、請求項1または2に記載の経口組成物。
- 前記アミノ酸が、アラニン、セリン、プロリン、メチオニンおよびアルギニンならびにその組合せから選択されるアミノ酸を含む、請求項1~3のいずれか一項に記載の経口組成物。
- 低甘味度甘味料をさらに含む、請求項1~4のいずれか一項に記載の経口組成物。
- 前記良味質高甘味度甘味料が、レバウジオシドD、レバウジオシドM、モグロシドV、羅漢果抽出物およびその組合せから選択される高甘味度甘味料を含む、請求項1~5のいずれか一項に記載の経口組成物。
- 前記低甘味度甘味料が、ヘキソース、ペントース、テトロース、末端糖がアルドースまたはケトースである多糖、糖アルコールおよびその組合せから選択される甘味料を含む、請求項5または6に記載の経口組成物。
- 前記低甘味度甘味料が、グルコース、スクロース、フルクトース、マルトース、オリゴ糖、異性化糖、乳糖、プシコース、アロース、タガトース、キシロース、リボースおよびその組合せから選択される甘味料を含む、請求項5または6に記載の経口組成物。
- 食品である、請求項1~8のいずれか一項に記載の経口組成物。
- 前記食品が飲料である、請求項9に記載の経口組成物。
- (a)甘味強度Xa相当の量の良味質高甘味度甘味料を添加すること、および
(b)味覚認知閾値未満のアミノ酸もしくはその塩を添加すること
を含む、請求項1~9のいずれか一項に記載の経口組成物の製造方法。 - 良味質高甘味度甘味料を含む経口組成物に、味覚認知閾値未満のアミノ酸を添加することを含む、前記経口組成物の甘味度を増強する方法。
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2020415059A AU2020415059A1 (en) | 2019-12-27 | 2020-12-24 | Oral composition with increased sweetness |
MX2022007913A MX2022007913A (es) | 2019-12-27 | 2020-12-24 | Composicion oral con dulzor aumentado. |
US17/787,751 US20230077392A1 (en) | 2019-12-27 | 2020-12-24 | Oral composition with increased sweetness |
EP20888742.2A EP3871513B1 (en) | 2019-12-27 | 2020-12-24 | Oral composition with increased sweetness |
CN202080090056.4A CN114867366A (zh) | 2019-12-27 | 2020-12-24 | 甜味增强的口服组合物 |
BR112022012237A BR112022012237A2 (pt) | 2019-12-27 | 2020-12-24 | Composição oral, e, métodos para produzir a composição oral e para realçar um grau de doçura de uma composição oral |
JP2021567617A JPWO2021132468A1 (ja) | 2019-12-27 | 2020-12-24 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019238755 | 2019-12-27 | ||
JP2019-238755 | 2019-12-27 | ||
JP2020098803 | 2020-06-05 | ||
JP2020-098803 | 2020-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021132468A1 true WO2021132468A1 (ja) | 2021-07-01 |
Family
ID=76573177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2020/048464 WO2021132468A1 (ja) | 2019-12-27 | 2020-12-24 | 甘味の増大した経口組成物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US20230077392A1 (ja) |
EP (1) | EP3871513B1 (ja) |
JP (1) | JPWO2021132468A1 (ja) |
CN (1) | CN114867366A (ja) |
AU (1) | AU2020415059A1 (ja) |
BR (1) | BR112022012237A2 (ja) |
MX (1) | MX2022007913A (ja) |
WO (1) | WO2021132468A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022050326A1 (ja) * | 2020-09-02 | 2022-03-10 | サントリーホールディングス株式会社 | 甘味の増大した果汁飲料 |
WO2022050327A1 (ja) * | 2020-09-02 | 2022-03-10 | サントリーホールディングス株式会社 | 甘味の増大した飲料 |
WO2022097687A1 (ja) * | 2020-11-05 | 2022-05-12 | サントリーホールディングス株式会社 | 甘味の増大した飲料 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009517021A (ja) * | 2005-11-23 | 2009-04-30 | ザ・コカ−コーラ・カンパニー | 経時的及び/又は香味プロファイルを改善した卓上用天然高甘味度甘味料組成物、その配合及び使用方法 |
WO2018225817A1 (ja) | 2017-06-08 | 2018-12-13 | サントリーホールディングス株式会社 | 甘味の増大した飲食品 |
JP2020098803A (ja) | 2020-03-09 | 2020-06-25 | 第一電子工業株式会社 | コネクタ |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9144251B2 (en) * | 2005-11-23 | 2015-09-29 | The Coca-Cola Company | High-potency sweetener composition with mineral and compositions sweetened therewith |
US20150189904A1 (en) * | 2005-11-23 | 2015-07-09 | The Coca-Cola Company | Natural High-Potency Sweetener Compositions with Improved Temporal Profile and/or Flavor Profile, Methods For Their Formulation, and Uses |
US20080292765A1 (en) * | 2007-05-22 | 2008-11-27 | The Coca-Cola Company | Sweetness Enhancers, Sweetness Enhanced Sweetener Compositions, Methods for Their Formulation, and Uses |
RU2658361C2 (ru) * | 2013-06-19 | 2018-06-21 | Конаджен Инк. | Ребаудиозид е и пищевые продукты, подслащенные ребаудиозидом е |
CN110463973A (zh) * | 2016-06-21 | 2019-11-19 | 厦门华高食品科技有限公司 | 一种罗汉果甜苷为主的复配甜味剂、其制备方法及用途 |
-
2020
- 2020-12-24 AU AU2020415059A patent/AU2020415059A1/en active Pending
- 2020-12-24 US US17/787,751 patent/US20230077392A1/en active Pending
- 2020-12-24 JP JP2021567617A patent/JPWO2021132468A1/ja active Pending
- 2020-12-24 WO PCT/JP2020/048464 patent/WO2021132468A1/ja unknown
- 2020-12-24 CN CN202080090056.4A patent/CN114867366A/zh active Pending
- 2020-12-24 EP EP20888742.2A patent/EP3871513B1/en active Active
- 2020-12-24 MX MX2022007913A patent/MX2022007913A/es unknown
- 2020-12-24 BR BR112022012237A patent/BR112022012237A2/pt unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009517021A (ja) * | 2005-11-23 | 2009-04-30 | ザ・コカ−コーラ・カンパニー | 経時的及び/又は香味プロファイルを改善した卓上用天然高甘味度甘味料組成物、その配合及び使用方法 |
WO2018225817A1 (ja) | 2017-06-08 | 2018-12-13 | サントリーホールディングス株式会社 | 甘味の増大した飲食品 |
JP2020098803A (ja) | 2020-03-09 | 2020-06-25 | 第一電子工業株式会社 | コネクタ |
Non-Patent Citations (11)
Title |
---|
AYUMI UCHIDANAO TAKAGIRIEKO HORIKIRIMIHO MATSUEYUMIKO UCHIYAMAMASASHI OMORI, RESEARCH BULLETIN OF OTSUMA WOMEN'S UNIVERSITY FOR HOME ECONOMICS, no. 49 |
EUR J CLIN NUTR, vol. 58, 2004, pages 629 - 636 |
FERNSTROM J. D.MUNGER S. D.SCLAFANI A.DE ARAUJO I. E.ROBERTS A.MOLINARY S., J. NUTR., vol. 142, 2012, pages 1134S - 1141S |
LI XSTASZEWSKI LXU HDURICK KZOLLER MADLER E., PROC NATL ACAD SCI U S A., vol. 99, no. 7, 2002, pages 4692 - 4696 |
NUEMKET NIPAWAN, YASUI NORIHISA, KUSAKABE YUKO, NOMURA YUKIYO, ATSUMI NANAKO, AKIYAMA SHUJI, NANGO ERIKO, KATO YUKINARI, KANEKO MI: "Structural basis for perception of diverse chemical substances by T1r taste receptors", NATURE COMMUNICATIONS, vol. 8, no. 1, 23 May 2017 (2017-05-23), XP055834918, DOI: 10.1038/ncomms15530 * |
REIKO OHMORI: "Comparisons of the taste sensitivity between three generations", THE BULLETIN OF THE FACULTY OF EDUCATION, UTSUNOMIYA UNIVERSITY, SECTION 1, vol. 63, 2013, pages 201 - 210 |
SUSAN S. SCHIFFMAN ET AL.: "Comparison of Taste Qualities and Thresholds of D- and L-Amino Acids", PHYSIOLOGY & BEHAVIOR, vol. 27, 1981, pages 51 - 59 |
SUSAN S. SCHIFFMAN ET AL.: "Comparison of Taste Qualities and Thresholds of D- and L-Amino Acids", PHYSIOLOGY BEHAVIOR, vol. 27, 1981, pages 51 - 59 |
THE JOURNAL OF JAPANESE SOCIETY OF STOMATOGNATHIC FUNCTION, vol. 20, 2014, pages 115 - 129 |
YUKI YAMAUCHI ET AL.: "WHOLE MOUTH GUSTATORY TEST (PARTI) - BASIC CONSIDERATIONS AND PRINCIPAL COMPONENT ANALYSIS", JOURNAL OF THE OTO-RHINO-LARYNGOLOGICAL SOCIETY OF JAPAN, vol. 98, no. 1, 1995, pages 119 - 129 |
ZHAO G. Q.ZHANG Y.HOON M. A.CHANDRASHEKAR J.ERLENBACH I.RYBA N. J. P.ZUKERL C. S., CELL, vol. 115, 2003, pages 255 - 266 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022050326A1 (ja) * | 2020-09-02 | 2022-03-10 | サントリーホールディングス株式会社 | 甘味の増大した果汁飲料 |
WO2022050327A1 (ja) * | 2020-09-02 | 2022-03-10 | サントリーホールディングス株式会社 | 甘味の増大した飲料 |
WO2022097687A1 (ja) * | 2020-11-05 | 2022-05-12 | サントリーホールディングス株式会社 | 甘味の増大した飲料 |
Also Published As
Publication number | Publication date |
---|---|
CN114867366A (zh) | 2022-08-05 |
AU2020415059A1 (en) | 2022-06-30 |
EP3871513B1 (en) | 2024-07-03 |
US20230077392A1 (en) | 2023-03-16 |
BR112022012237A2 (pt) | 2022-08-30 |
EP3871513A4 (en) | 2022-03-23 |
JPWO2021132468A1 (ja) | 2021-07-01 |
EP3871513A1 (en) | 2021-09-01 |
MX2022007913A (es) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6727886B2 (ja) | レバウディオサイドbを含有するステビアブレンド | |
WO2021132468A1 (ja) | 甘味の増大した経口組成物 | |
US9138011B2 (en) | Taste-masking compositions, sweetener compositions and consumable product compositions containing the same | |
TWI657746B (zh) | 含有甜葉菊苷e之可食用產品及使用其製備和強化可食用產品之甜味的方法 | |
US20130136839A1 (en) | Taste-Masking Compositions, Sweetener Compositions and Consumable Product Compositions Containing the Same | |
JPWO2018225817A1 (ja) | 甘味の増大した飲食品 | |
EP2785199A2 (en) | Taste-masking compositions, sweetener compositions and consumable product compositions containing the same | |
WO2019189898A1 (ja) | 甘味受容体(t1r2/t1r3)以外も甘味応答せしめる甘味組成物 | |
EP3236776A1 (en) | Taste modifying compositions | |
JP2022166142A (ja) | 甘味後引きを低減する方法 | |
US20220071238A1 (en) | Effervescent beverage in which quality of taste resulting from sugars and sweeteners is improved | |
US20160183576A1 (en) | Taste modifying compositions | |
US20230389577A1 (en) | Fruit juice beverage with intensified sweet taste | |
WO2021132467A1 (ja) | 甘味の増大した経口組成物 | |
US20230320385A1 (en) | Beverage with increased sweetness | |
US20160183580A1 (en) | Taste modifying compositions | |
WO2022145481A1 (ja) | 甘味の増大した経口組成物 | |
US20160183579A1 (en) | Taste modifying compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2020888742 Country of ref document: EP Effective date: 20210527 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20888742 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2021567617 Country of ref document: JP Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112022012237 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2020415059 Country of ref document: AU Date of ref document: 20201224 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 112022012237 Country of ref document: BR Kind code of ref document: A2 Effective date: 20220620 |